<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" id="ame270053" xml:lang="en" article-type="review-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Animal Model Exp Med</journal-id><journal-id journal-id-type="iso-abbrev">Animal Model Exp Med</journal-id><journal-id journal-id-type="pmc-domain-id">3615</journal-id><journal-id journal-id-type="pmc-domain">animalmod</journal-id><journal-id journal-id-type="publisher-id">AME2</journal-id><journal-title-group><journal-title>Animal Models and Experimental Medicine</journal-title></journal-title-group><issn pub-type="ppub">2096-5451</issn><issn pub-type="epub">2576-2095</issn><publisher><publisher-name>Wiley</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12431582</article-id><article-id pub-id-type="pmcid-ver">PMC12431582.1</article-id><article-id pub-id-type="pmcaid">12431582</article-id><article-id pub-id-type="pmcaiid">12431582</article-id><article-id pub-id-type="pmid">40628671</article-id><article-id pub-id-type="doi">10.1002/ame2.70053</article-id><article-id pub-id-type="publisher-id">AME270053</article-id><article-id pub-id-type="other">AMEM-2025-0128.R1</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="overline"><subject>Review</subject></subj-group><subj-group subj-group-type="heading"><subject>Regular Article</subject><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></subj-group></article-categories><title-group><article-title>Therapeutic targeting of myeloid cells in liver fibrosis: Mechanisms and clinical prospects</article-title><alt-title alt-title-type="left-running-head">Wang et&#160;al.</alt-title></title-group><contrib-group><contrib id="ame270053-cr-0001" contrib-type="author"><name name-style="western"><surname>Wang</surname><given-names initials="Y">Yue</given-names></name><xref rid="ame270053-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="ame270053-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="ame270053-cr-0002" contrib-type="author"><name name-style="western"><surname>Liu</surname><given-names initials="Y">Yiming</given-names></name><xref rid="ame270053-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="ame270053-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="ame270053-cr-0003" contrib-type="author"><name name-style="western"><surname>Chen</surname><given-names initials="D">Dan</given-names></name><xref rid="ame270053-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="ame270053-cr-0004" contrib-type="author" corresp="yes"><name name-style="western"><surname>Liu</surname><given-names initials="L">Leiming</given-names></name><xref rid="ame270053-aff-0003" ref-type="aff">
<sup>3</sup>
</xref><address><email>liuleiming@zjsru.edu.cn</email></address></contrib><contrib id="ame270053-cr-0005" contrib-type="author" corresp="yes"><name name-style="western"><surname>Sun</surname><given-names initials="L">Leimin</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-0231-2465</contrib-id><xref rid="ame270053-aff-0004" ref-type="aff">
<sup>4</sup>
</xref><address><email>sunlm@zju.edu.cn</email></address></contrib><contrib id="ame270053-cr-0006" contrib-type="author" corresp="yes"><name name-style="western"><surname>Zhang</surname><given-names initials="L">Lingling</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-9519-1775</contrib-id><xref rid="ame270053-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="ame270053-aff-0002" ref-type="aff">
<sup>2</sup>
</xref><address><email>linglingzhang@zju.edu.cn</email></address></contrib></contrib-group><aff id="ame270053-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">Department of Gastroenterology, Center for Metabolic Medicine, The Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, International Institutes of Medicine</named-content>
<institution>Zhejiang University</institution>
<city>Yiwu</city>
<country country="CN">China</country>
</aff><aff id="ame270053-aff-0002">
<label>
<sup>2</sup>
</label>
<named-content content-type="organisation-division">Department of Hematology, Center for Metabolic Medicine, The Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, International Institutes of Medicine</named-content>
<institution>Zhejiang University</institution>
<city>Yiwu</city>
<country country="CN">China</country>
</aff><aff id="ame270053-aff-0003">
<label>
<sup>3</sup>
</label>
<named-content content-type="organisation-division">Key Laboratory of Artificial Organs and Computational Medicine in Zhejiang Province</named-content>
<institution>Institute of Translational Medicine,Shulan International Medical College, Zhejiang Shuren University</institution>
<city>Hangzhou</city>
<country country="CN">China</country>
</aff><aff id="ame270053-aff-0004">
<label>
<sup>4</sup>
</label>
<named-content content-type="organisation-division">Department of Gastroenterology</named-content>
<institution>Sir Run Run Shaw Hospital, Zhejiang University School of Medicine</institution>
<city>Hangzhou</city>
<country country="CN">China</country>
</aff><author-notes><corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break/>
Lingling Zhang, Department of Gastroenterology, Center for Metabolic Medicine, The Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, International Institutes of Medicine, Zhejiang University, Yiwu 322000, China.<break/>
Email: <email>linglingzhang@zju.edu.cn</email><break/>
Leimin Sun, Department of Gastroenterology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou 310000, China.<break/>
Email: <email>sunlm@zju.edu.cn</email><break/>
Leiming Liu, Key Laboratory of Artificial Organs and Computational Medicine in Zhejiang Province, Institute of Translational Medicine,Shulan International Medical College, Zhejiang Shuren University, Hangzhou 310015, China.<break/>
Email: <email>liuleiming@zjsru.edu.cn</email><break/></corresp></author-notes><pub-date pub-type="epub"><day>08</day><month>7</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>7</month><year>2025</year></pub-date><volume>8</volume><issue seq="80">7</issue><issue-id pub-id-type="pmc-issue-id">496817</issue-id><issue-id pub-id-type="doi">10.1002/ame2.v8.7</issue-id><issue-title content-type="special-issue-title">Themed Issue: Mechanism Verification of Plant Bioactive Components</issue-title><fpage>1215</fpage><lpage>1228</lpage><history><date date-type="rev-recd"><day>22</day><month>5</month><year>2025</year></date><date date-type="received"><day>10</day><month>4</month><year>2025</year></date><date date-type="accepted"><day>08</day><month>6</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>08</day><month>07</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>13</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-13 17:25:36.317"><day>13</day><month>09</month><year>2025</year></date></event></pub-history><permissions><copyright-statement content-type="article-copyright">&#169; 2025 The Author(s). <italic toggle="yes">Animal Models and Experimental Medicine</italic> published by John Wiley &amp; Sons Australia, Ltd on behalf of The Chinese Association for Laboratory Animal Sciences.</copyright-statement><license><ali:license_ref specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link> License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non&#8208;commercial and no modifications or adaptations are made.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="AME2-8-1215.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pdf" xlink:href="file:AME2-8-1215.pdf"/><abstract><title>Abstract</title><p>Liver fibrosis, a hallmark pathological endpoint of chronic aging&#8208;related liver diseases, remains a clinical challenge with limited therapeutic options. In healthy liver, myeloid cells constitute &lt;5% of total hepatic immune cells, primarily comprising tissue&#8208;resident Kupffer cells. However, during aging or chronic injury, bone marrow&#8211;derived myeloid cell recruitment increases by two&#8208; to threefold in murine fibrotic models, reaching 15%&#8211;20% of intrahepatic immune populations. These infiltrating myeloid subsets exhibit functional plasticity, dynamically differentiating into pro&#8208;inflammatory macrophages or fibrosis&#8208;promoting Kupffer&#8208;like cells, contingent upon chemokine gradients (e.g., CCL2/CCR2 axis) and damage&#8208;associated molecular patterns (DAMPs). This review systematically examines the regulatory mechanisms of myeloid cells in liver fibrogenesis, with particular emphasis on their developmental origins, hepatic recruitment dynamics, functional heterogeneity, and pathogenic contributions to fibrosis. Furthermore, signaling pathways involving myeloid cells in liver fibrosis and therapeutic approaches modulating their differentiation and recruitment are discussed in this review.</p></abstract><abstract abstract-type="graphical"><p>This review systematically summarizes the origin, recruitment, and differentiation regulation mechanisms of myeloid cells in driving hepatic fibrosis progression. By targeting these three critical phases, potential therapeutic strategies for liver fibrosis can be explored. The review further elucidates the regulatory roles, underlying mechanisms, and translational applications of myeloid cells in hepatic fibrosis, offering insights for future research and clinical interventions.<boxed-text position="anchor" content-type="graphic" id="ame270053-blkfxd-0001" orientation="portrait"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-1" orientation="portrait" xlink:href="AME2-8-1215-g003.jpg"/></boxed-text>
</p></abstract><kwd-group kwd-group-type="author-generated"><kwd id="ame270053-kwd-0001">aging</kwd><kwd id="ame270053-kwd-0002">hematopoiesis</kwd><kwd id="ame270053-kwd-0003">immune microenvironment</kwd><kwd id="ame270053-kwd-0004">liver fibrosis</kwd><kwd id="ame270053-kwd-0005">myeloid cells</kwd></kwd-group><funding-group><award-group id="funding-0001"><funding-source><institution-wrap><institution>National Key Research and Development Program of China</institution><institution-id institution-id-type="doi">10.13039/501100012166</institution-id></institution-wrap></funding-source><award-id>2021YFA0804903</award-id></award-group><award-group id="funding-0002"><funding-source><institution-wrap><institution>National Natural Science Foundation of China</institution><institution-id institution-id-type="doi">10.13039/501100001809</institution-id></institution-wrap></funding-source><award-id>882171545</award-id><award-id>91949125</award-id></award-group><award-group id="funding-0003"><funding-source><institution-wrap><institution>The Start&#8208;up Fund for Distinguished Research Fellows, the International Institute of Health Medicine, Zhejiang University</institution></institution-wrap></funding-source><award-id>Q22005</award-id></award-group></funding-group><counts><fig-count count="3"/><table-count count="2"/><page-count count="14"/><word-count count="10600"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>July 2025</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.6.2 mode:remove_FC converted:12.09.2025</meta-value></custom-meta></custom-meta-group></article-meta><notes><p content-type="self-citation">
<mixed-citation publication-type="journal" id="AME270053-cit-2001"><string-name name-style="western"><surname>Wang</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Sun</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>L</given-names></string-name>. <article-title>Therapeutic targeting of myeloid cells in liver fibrosis: Mechanisms and clinical prospects</article-title>. <source>Anim Models Exp Med</source>. <year>2025</year>;<volume>8</volume>:<fpage>1215</fpage>&#8208;<lpage>1228</lpage>. doi:<pub-id pub-id-type="doi">10.1002/ame2.70053</pub-id><pub-id pub-id-type="pmcid">PMC12431582</pub-id><pub-id pub-id-type="pmid">40628671</pub-id></mixed-citation>
</p></notes></front><body id="ame270053-body-0001"><sec id="ame270053-sec-0001"><label>1</label><title>INTRODUCTION</title><p>The liver, a vital organ for detoxification and metabolism, is susceptible to chronic injuries (viral infections, toxins, metabolic stress), leading to fibrosis as a convergent pathological outcome.<xref rid="ame270053-bib-0001" ref-type="bibr">
<sup>1</sup>
</xref>, <xref rid="ame270053-bib-0002" ref-type="bibr">
<sup>2</sup>
</xref> Liver fibrosis, a hallmark pathological endpoint of chronic liver disease (CLD), is defined by excessive extracellular matrix (ECM) deposition and architectural remodeling. Sustained hepatic injury activates lysyl oxidase (LOX) family enzymes (e.g., LOXL2), which catalyze ECM cross&#8208;linking to form stable fibrous septa.<xref rid="ame270053-bib-0003" ref-type="bibr">
<sup>3</sup>
</xref> This progressive architectural distortion culminates in cirrhosis, characterized by severe complications, including portal hypertension, hepatic encephalopathy, and potential progression to hepatocellular carcinoma. Although liver transplantation serves as the gold&#8208;standard therapy for end&#8208;stage cirrhosis, its clinical application is constrained by donor shortages, immune rejection risks, and prohibitive costs.<xref rid="ame270053-bib-0004" ref-type="bibr">
<sup>4</sup>
</xref> The urgency of advancing hepatic fibrosis research is underscored by the escalating global prevalence of cirrhosis. CLDs collectively affect approximately 25% of the worldwide population, with hepatic fibrosis developing in nearly 20% of these cases.<xref rid="ame270053-bib-0005" ref-type="bibr">
<sup>5</sup>
</xref>, <xref rid="ame270053-bib-0006" ref-type="bibr">
<sup>6</sup>
</xref> This clinical progression culminates in cirrhosis, which has emerged as a major global health challenge. According to mortality statistics released by the World Health Organization (WHO) in 2024, cirrhosis&#8208;related complications now account for over 1.5 million deaths annually, further emphasizing the critical need for targeted therapeutic interventions.<xref rid="ame270053-bib-0007" ref-type="bibr">
<sup>7</sup>
</xref> Despite this significant disease burden, there remains a critical lack of effective therapeutic interventions capable of reversing established fibrosis. This therapeutic gap highlights the imperative need for in&#8208;depth investigations into the fundamental pathophysiological mechanisms driving fibrogenesis, which could inform the development of targeted antifibrotic strategies.</p><p>The hepatic immune microenvironment has been identified as a critical regulator of fibrosis pathogenesis. Single&#8208;cell sequencing results demonstrate that during liver injury or infection, there is a significant increase in the recruitment of myeloid cells to the liver, accompanied by phenotypic changes in their subsets.<xref rid="ame270053-bib-0008" ref-type="bibr">
<sup>8</sup>
</xref>, <xref rid="ame270053-bib-0009" ref-type="bibr">
<sup>9</sup>
</xref>, <xref rid="ame270053-bib-0010" ref-type="bibr">
<sup>10</sup>
</xref> Interactions between immune cells and cytokines during the transition from acute injury to chronic fibrosis present potential therapeutic targets for disrupting pro&#8208;fibrotic pathways.<xref rid="ame270053-bib-0011" ref-type="bibr">
<sup>11</sup>
</xref> Among immune cells, distinct subsets of hepatic macrophages exhibit dual functions, promoting both fibrosis progression and resolution. This review evaluates the roles of myeloid cells in sustaining hepatic immune homeostasis and driving disease progression. We analyze cellular and molecular mechanisms underlying myeloid cell behavior in physiological and pathological states, with a focus on immune niche remodeling, and assess therapeutic strategies that modulate myeloid cell activity to mitigate fibrosis.</p></sec><sec id="ame270053-sec-0002"><label>2</label><title>REGULATORY MECHANISMS OF HEPATIC MYELOID CELL IN LIVER FIBROSIS</title><sec id="ame270053-sec-0003"><label>2.1</label><title>Origin and recruitment of hepatic myeloid cell</title><p>The liver harbors a unique immune network due to its dual blood supply (portal vein and hepatic artery), exposing it to gut&#8208;derived antigens and pathogens. There includes resident and recruited immune cells. Among them, myeloid cells, including macrophages, neutrophils, monocytes, eosinophils, and dentritic cells, are central immunoregulators.</p><p>Under normal physiological conditions, hematopoietic stem cells (HSCs) give rise to all mature blood cells through a tightly regulated differentiation process. This differentiation primarily follows two major lineages: the lymphoid lineage and the myeloid lineage. Initially, HSCs differentiate into common lymphoid progenitors (CLPs) and common myeloid progenitors (CMPs). Myeloid progenitors further diversify into granulocytes (including neutrophils, eosinophils, and basophils), monocytes/macrophages, erythrocytes, megakaryocytes/platelets, and dendritic cells (DCs), each playing distinct roles in immunity, oxygen transport, and tissue repair.<xref rid="ame270053-bib-0012" ref-type="bibr">
<sup>12</sup>
</xref> This highly orchestrated differentiation is governed by a combination of cell&#8208;intrinsic transcriptional programs and extrinsic signals from the bone marrow niche, including cytokine gradients and stromal cell interactions.<xref rid="ame270053-bib-0013" ref-type="bibr">
<sup>13</sup>
</xref> The detailed myeloid and lymphoid lineage differentiation pathways of HSCs are schematically illustrated in Figure&#160;<xref rid="ame270053-fig-0001" ref-type="fig">1</xref>.</p><fig position="float" fig-type="FIGURE" id="ame270053-fig-0001" orientation="portrait"><label>FIGURE 1</label><caption><p>Differentiation lineage of hematopoietic stem cells (HSCs). HSCs primarily differentiate into two types of progenitor cells: common lymphoid progenitors and common myeloid progenitors. Lymphoid progenitors further develop into B cells, T cells, and natural killer (NK) cells. Myeloid progenitors differentiate into neutrophils, eosinophils, basophils, monocytes, immature dendritic cells (DCs), mast cell precursors, erythrocytes, and platelets. After migrating to tissues and organs, myeloid cells undergo further specialization: monocytes mature into macrophages, immature DCs become mature DCs, and mast cell precursors develop into mast cells, each performing distinct immune functions.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-3" orientation="portrait" xlink:href="AME2-8-1215-g002.jpg"/></fig><p>In the context of hepatic fibrosis, the predominant myeloid cell populations are predominantly bone marrow&#8211;derived, with their quantitative and qualitative characteristics being directly governed by HSCs' differentiation propensity. The aging process induces functional deterioration in core metabolic organs, significantly elevating susceptibility to hepatic fibrosis, renal dysfunction, and cardiovascular pathologies.<xref rid="ame270053-bib-0014" ref-type="bibr">
<sup>14</sup>
</xref> This age&#8208;related deterioration is mechanistically linked to systemic alterations in hematopoiesis, particularly the development of myeloid&#8208;biased differentiation in HSCs, which operates in concert with chronic low&#8208;grade inflammation and mitochondrial dysfunction to drive tissue degeneration.<xref rid="ame270053-bib-0015" ref-type="bibr">
<sup>15</sup>
</xref>, <xref rid="ame270053-bib-0016" ref-type="bibr">
<sup>16</sup>
</xref> The pathological myeloid skewing of aged HSCs manifests through three interconnected phenomena: diminished lymphopoiesis leading to impaired adaptive immunity, exaggerated myelopoiesis resulting in expanded pro&#8208;inflammatory effector populations, and dysregulated cytokine production that perpetuates immune imbalance. This triad of hematopoietic dysfunction not only increases vulnerability to infections and hematological malignancies but also establishes a pro&#8208;fibrotic milieu that accelerates end&#8208;organ damage.<xref rid="ame270053-bib-0017" ref-type="bibr">
<sup>17</sup>
</xref>
</p><p>At the molecular level, inflammation&#8208;induced nuclear factor kappa B (NF&#8208;&#954;B) activation in aged HSCs orchestrates a transcriptional reprogramming of hematopoietic differentiation, characterized by suppression of lymphoid lineage determinants like Ikzf1 and concomitant upregulation of myeloid&#8208;specific factors, including Cebpa. This shift is further amplified by selective elevation of cell cycle regulators (Myc, Ccnb2) in myeloid progenitors, creating a self&#8208;reinforcing loop that drives excessive myeloid output.<xref rid="ame270053-bib-0018" ref-type="bibr">
<sup>18</sup>
</xref> Transplantation studies using aged marrow have conclusively demonstrated that myeloid&#8208;skewed HSCs autonomously propagate their pathological differentiation program to recipient animals, resulting in increased circulating myeloid cells and enhanced tissue infiltration by monocyte&#8208;derived macrophages regardless of the host's age. Importantly, these aberrant myeloid populations exhibit distinct pro&#8208;fibrotic polarization marked by excessive transforming growth factor &#946; (TGF&#8208;&#946;) production, directly contributing to ECM deposition and architectural distortion in target organs like the liver and lungs.<xref rid="ame270053-bib-0014" ref-type="bibr">
<sup>14</sup>
</xref>, <xref rid="ame270053-bib-0019" ref-type="bibr">
<sup>19</sup>
</xref>
</p><p>The consequences of myeloid skewing extend beyond local tissue damage to encompass systemic metabolic dysregulation. The chronic inflammatory state linked to myeloid&#8208;biased hematopoiesis accelerates the progression of age&#8208;related diseases, including coronary artery disease, congestive heart failure, stroke, chronic obstructive pulmonary disease, osteoporosis, and periodontitis,<xref rid="ame270053-bib-0020" ref-type="bibr">
<sup>20</sup>
</xref>, <xref rid="ame270053-bib-0021" ref-type="bibr">
<sup>21</sup>
</xref>, <xref rid="ame270053-bib-0022" ref-type="bibr">
<sup>22</sup>
</xref> while also contributing to insulin resistance and lipid metabolism disorders. These effects exacerbate comorbid conditions such as type 2 diabetes and obesity, which are frequently associated with progressive liver disease.<xref rid="ame270053-bib-0023" ref-type="bibr">
<sup>23</sup>
</xref>, <xref rid="ame270053-bib-0024" ref-type="bibr">
<sup>24</sup>
</xref>, <xref rid="ame270053-bib-0025" ref-type="bibr">
<sup>25</sup>
</xref> Epigenetic alterations, particularly the age&#8208;related decline in DNMT3A and TET2 function within hematopoietic stem and progenitor cells (HSPCs), further entrench myeloid bias by derepressing pro&#8208;inflammatory gene networks.<xref rid="ame270053-bib-0026" ref-type="bibr">
<sup>26</sup>
</xref> Together, these interconnected mechanisms create a perfect storm of immune dysfunction, metabolic disturbance, and fibrotic progression that underscores the central role of HSC aging in multiorgan pathology.<xref rid="ame270053-bib-0023" ref-type="bibr">
<sup>23</sup>
</xref>
</p><sec id="ame270053-sec-0004"><label>2.1.1</label><title>Monocytes</title><p>The recruitment of myeloid cells from bone marrow to the hepatic immune microenvironment represents a critical step in fibrotic pathogenesis, with monocyte&#8208;derived macrophages playing a central role. Monocytes are broadly categorized into two subsets distinguished by chemokine receptor profiles and surface marker expression.<xref rid="ame270053-bib-0009" ref-type="bibr">
<sup>9</sup>
</xref> Inflammatory monocytes in mice, characterized by high Ly&#8208;6C and CD11b expression (equivalent to CD14<sup>+</sup>CD16<sup>&#8722;</sup> monocytes in human), exhibit elevated CCR2 and low CX3CR1 levels. Under steady&#8208;state conditions, these Ly&#8208;6C<sup>hi</sup> monocytes typically constitute 2%&#8211;5% of circulating immune cells under homeostasis but rapidly mobilize to inflammatory sites upon stimulation. Bone marrow stromal cells, including mesenchymal stem cells (MSCs) and CXCL12&#8208;abundant reticular cells, respond to pathogen&#8208;associated molecular patterns through toll&#8208;like receptor (TLR) activation, triggering CCL2 release that facilitates Ly&#8208;6C<sup>hi</sup> monocytes egress via CCR2 binding.<xref rid="ame270053-bib-0027" ref-type="bibr">
<sup>27</sup>
</xref> The establishment of CCL2 chemotactic gradients, stabilized through interactions with endothelial glycosaminoglycans or transendothelial transport mediated by Duffy antigen receptor, directs monocyte trafficking to injured tissues.<xref rid="ame270053-bib-0028" ref-type="bibr">
<sup>28</sup>
</xref>, <xref rid="ame270053-bib-0029" ref-type="bibr">
<sup>29</sup>
</xref>, <xref rid="ame270053-bib-0030" ref-type="bibr">
<sup>30</sup>
</xref> In contrast, the nonclassical monocyte subset in mice (Ly&#8208;6C<sup>lo</sup>) has low CCR2 and high CX3CR1 expression, corresponding to CD14<sup>+</sup>CD16<sup>+</sup> monocytes in humans. These cells perform vascular surveillance by engaging endothelial CX3CL1 (fractalkine) through CX3CR1, enabling early pathogen detection and resolution of inflammation via anti&#8208;inflammatory mediators.<xref rid="ame270053-bib-0031" ref-type="bibr">
<sup>31</sup>
</xref>, <xref rid="ame270053-bib-0032" ref-type="bibr">
<sup>32</sup>
</xref>
</p></sec><sec id="ame270053-sec-0005"><label>2.1.2</label><title>Neutrophil</title><p>Neutrophil recruitment follows distinct but equally regulated pathways, with these granulocytes being continuously produced in bone marrow at approximately 2&#8201;&#215;&#8201;10<xref rid="ame270053-bib-0011" ref-type="bibr">
<sup>11</sup>
</xref> cells per day under the regulation of granulocyte colony&#8208;stimulating factor/granulocyte&#8208;macrophage colony&#8208;stimulating factor (G&#8208;CSF/GM&#8208;CSF), which is modulated by interleukin 17 (IL&#8208;17) (from &#947;&#948;T and NKT cells) and IL&#8208;23 (from tissue&#8208;resident macrophages and DCs).<xref rid="ame270053-bib-0033" ref-type="bibr">
<sup>33</sup>
</xref> Their maturation is transcriptionally controlled by PU.1 and C/EBP&#945;.<xref rid="ame270053-bib-0034" ref-type="bibr">
<sup>34</sup>
</xref>, <xref rid="ame270053-bib-0035" ref-type="bibr">
<sup>35</sup>
</xref> During hepatic injury, neutrophils employ a unique CD44&#8208;hyaluronan&#8208;mediated adhesion mechanism to sinusoidal endothelia that differs from conventional integrin&#8208;dependent pathways. Liver sinusoidal endothelial cells (LSECs) express hyaluronan, which interacts with CD44 on neutrophils, facilitating their precise localization to inflammatory foci.<xref rid="ame270053-bib-0010" ref-type="bibr">
<sup>10</sup>
</xref> Besides, ATP released by necrotic hepatocytes activates the NLRP3 inflammasome via P2X7 receptor signaling, generating an intravascular chemokine gradient (e.g., CXCL2) that guides neutrophil migration.<xref rid="ame270053-bib-0036" ref-type="bibr">
<sup>36</sup>
</xref> Formyl peptides from necrotic cells further direct neutrophils to injury sites. Furthermore, the TLR4 ligand S100A9 protein secreted in hepatitis was a key regulator of hepatic CXCL2 expression and neutrophil recruitment.<xref rid="ame270053-bib-0037" ref-type="bibr">
<sup>37</sup>
</xref> Together, these carefully orchestrated recruitment mechanisms ensure the timely delivery of myeloid effectors to sites of liver injury while maintaining the capacity for both pro&#8208;inflammatory and resolution responses critical to fibrotic progression.</p></sec><sec id="ame270053-sec-0006"><label>2.1.3</label><title>Other cells</title><p>In the progression of liver fibrosis, nondominant myeloid cells play relatively minor roles and are recruited to the liver in smaller quantities. During hepatic injury, hepatocytes, stellate cells, and macrophages secrete the chemokine CCL11, which recruits eosinophils via CCR3 receptor binding.<xref rid="ame270053-bib-0038" ref-type="bibr">
<sup>38</sup>
</xref> Concurrently, IL&#8208;5 produced by Th2 cells and group 2 innate lymphoid cells (ILC2s) enhances eosinophilopoiesis in the bone marrow and promotes their migration to the liver.<xref rid="ame270053-bib-0039" ref-type="bibr">
<sup>39</sup>
</xref> In chronic liver inflammation, LSECs upregulate CXCL12 expression, facilitating the recruitment of CXCR4<sup>+</sup> basophils.<xref rid="ame270053-bib-0040" ref-type="bibr">
<sup>40</sup>
</xref>, <xref rid="ame270053-bib-0041" ref-type="bibr">
<sup>41</sup>
</xref>, <xref rid="ame270053-bib-0042" ref-type="bibr">
<sup>42</sup>
</xref> Activated hepatic stellate cells secrete stem cell factor (SCF) during fibrosis, driving the recruitment of mast cell (MC) progenitors through c&#8208;Kit receptor signaling. Necrotic hepatocytes release CXCL1, which attracts mature MCs via the CXCL1/CXCR2 axis.<xref rid="ame270053-bib-0043" ref-type="bibr">
<sup>43</sup>
</xref>, <xref rid="ame270053-bib-0044" ref-type="bibr">
<sup>44</sup>
</xref> The hepatic Flt3 ligand (Flt3L) supports the differentiation and migration of bone marrow&#8211;derived DC precursors to the liver.<xref rid="ame270053-bib-0045" ref-type="bibr">
<sup>45</sup>
</xref> Additionally, pathogen&#8208;associated molecules, such as lipopolysaccharide (LPS), activate the TLR4 pathway in hepatic macrophages, inducing the secretion of CXCL9 and CXCL10, which recruit CXCR3&#8208;expressing CD103<sup>+</sup> DCs to regulate the hepatic immune microenvironment.<xref rid="ame270053-bib-0046" ref-type="bibr">
<sup>46</sup>
</xref>
</p></sec></sec><sec id="ame270053-sec-0007"><label>2.2</label><title>Functional roles of hepatic myeloid cells in fibrogenesis</title><p>Hepatic myeloid cells exhibit remarkable heterogeneity and functional diversity, playing pivotal roles in maintaining immune homeostasis in the liver. Following hepatic injury, these cells are recruited to the liver and differentiate into effector populations, actively participating in immune responses and pathological processes. Their dynamic involvement represents a central mechanism in the progression of liver fibrosis. As summarized in Table&#160;<xref rid="ame270053-tbl-0001" ref-type="table">1</xref>, we provide a comprehensive classification of liver myeloid subsets along with their characteristic surface marker profiles.</p><table-wrap position="float" id="ame270053-tbl-0001" content-type="TABLE" orientation="portrait"><label>TABLE 1</label><caption><p>Myeloid cell subsets.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Class</th><th align="left" valign="bottom" rowspan="1" colspan="1">Subsets</th><th align="left" valign="bottom" rowspan="1" colspan="1">Makers</th><th align="left" valign="bottom" rowspan="1" colspan="1">Specific features</th></tr></thead><tbody valign="top"><tr><td align="left" rowspan="4" valign="top" colspan="1">Macrophage</td><td align="left" valign="top" rowspan="1" colspan="1">Kupffer cell</td><td align="left" valign="top" rowspan="1" colspan="1">F4/80<sup>+</sup>, CLEC4F<sup>+</sup>, TIM4<sup>+</sup>
</td><td align="left" valign="top" rowspan="1" colspan="1">Antigen&#8208;presenting, clearance of debris, regulation of lipid and iron</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Ly&#8208;6C<sup>hi</sup>MoDM</td><td align="left" valign="top" rowspan="1" colspan="1">CD11b<sup>+</sup>, F4/80<sup>+</sup>, Ly&#8208;6C<sup>hi</sup>
</td><td align="left" valign="top" rowspan="1" colspan="1">Pro&#8208;inflammatory cytokines and chemokines secretion</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Ly&#8208;6C<sup>lo</sup>MoDM</td><td align="left" valign="top" rowspan="1" colspan="1">CD11b<sup>+</sup>, F4/80<sup>+</sup>, Ly&#8208;6C<sup>lo</sup>
</td><td align="left" valign="top" rowspan="1" colspan="1">Matrix resolution</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">LAM</td><td align="left" valign="top" rowspan="1" colspan="1">F4/80+, CD68+, CD11b+, CD9<sup>+</sup>, TREM2<sup>+</sup>, CD36<sup>+</sup>
</td><td align="left" valign="top" rowspan="1" colspan="1">Regulate lipid metabolism, efferocytosis</td></tr><tr><td align="left" rowspan="2" valign="top" colspan="1">Monocyte</td><td align="left" valign="top" rowspan="1" colspan="1">
<p>Ly&#8208;6C<sup>hi</sup>
</p>
<p>monocytes</p>
</td><td align="left" valign="top" rowspan="1" colspan="1">CCR2<sup>+</sup>, CX3CL1<sup>&#8722;</sup>, Ly&#8208;6C<sup>hi</sup>
</td><td align="left" valign="top" rowspan="1" colspan="1">Inflammatory response</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<p>Ly&#8208;6C<sup>hi</sup>
</p>
<p>monocytes</p>
</td><td align="left" valign="top" rowspan="1" colspan="1">CCR2<sup>&#8722;</sup>, CX3CL1<sup>+</sup>, Ly&#8208;6C<sup>lo</sup>
</td><td align="left" valign="top" rowspan="1" colspan="1">Inflammatory response subsidence</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Neutrophil</td><td align="left" valign="top" rowspan="1" colspan="1">&#8208;</td><td align="left" valign="top" rowspan="1" colspan="1">CD11b<sup>+</sup>, Ly&#8208;6G<sup>+</sup>
</td><td align="left" valign="top" rowspan="1" colspan="1">Phagocytosis, degranulation, NETs</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Eosinophil</td><td align="left" valign="top" rowspan="1" colspan="1">&#8208;</td><td align="left" valign="top" rowspan="1" colspan="1">CD11b<sup>&#8722;</sup>, CD11b<sup>&#8722;</sup>, SiglecF<sup>+</sup>
</td><td align="left" valign="top" rowspan="1" colspan="1">Protective function</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Basophil</td><td align="left" valign="top" rowspan="1" colspan="1">&#8208;</td><td align="left" valign="top" rowspan="1" colspan="1">Fc&#949;RI<sup>+</sup>, CD11b<sup>+</sup>, CD44<sup>+</sup>
</td><td align="left" valign="top" rowspan="1" colspan="1">Type 2 immunity</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Mast cell</td><td align="left" valign="top" rowspan="1" colspan="1">&#8208;</td><td align="left" valign="top" rowspan="1" colspan="1">c&#8208;Kit<sup>+</sup>, Fc&#949;RI<sup>+</sup>
</td><td align="left" valign="top" rowspan="1" colspan="1">Ductular reaction</td></tr><tr><td align="left" rowspan="4" valign="top" colspan="1">LDC</td><td align="left" valign="top" rowspan="1" colspan="1">CD103<sup>+</sup>DC</td><td align="left" valign="top" rowspan="1" colspan="1">Lin<sup>&#8722;</sup>, PDCA1<sup>&#8722;</sup>, CD11c<sup>+</sup>, MHCII<sup>+</sup>, CD103<sup>+</sup>, CD11b<sup>+</sup>
</td><td align="left" valign="top" rowspan="1" colspan="1">Resemble lymphoid tissue resident&#8208;DC</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD103<sup>&#8722;</sup>DC</td><td align="left" valign="top" rowspan="1" colspan="1">Lin<sup>&#8722;</sup>, PDCA1<sup>&#8722;</sup>, CD11c<sup>+</sup>, MHCII<sup>+</sup>, CD103<sup>&#8722;</sup>, CD11b<sup>+</sup>
</td><td align="left" valign="top" rowspan="1" colspan="1">Derived from both resident DC precursor and monocyte lineage</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">pDC</td><td align="left" valign="top" rowspan="1" colspan="1">Lin<sup>&#8722;</sup>, PDCA1<sup>&#8722;</sup>, CD11c<sup>+</sup>
</td><td align="left" valign="top" rowspan="1" colspan="1">IFN&#8208;I production and antiviral response</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">LDC precursor</td><td align="left" valign="top" rowspan="1" colspan="1">Lin<sup>&#8722;</sup>, CD11c<sup>+</sup>, MHCII<sup>+</sup>, SIRPa<sup>lo</sup>
</td><td align="left" valign="top" rowspan="1" colspan="1">LDC proliferation in&#160;situ</td></tr></tbody></table><table-wrap-foot id="ame270053-ntgp-0001"><fn id="ame270053-note-0001"><p>Abbreviations: LDC, hepatic dendritic cell; NETs, neutrophil extracellular traps.</p></fn></table-wrap-foot></table-wrap><sec id="ame270053-sec-0008"><label>2.2.1</label><title>Macrophages</title><p>Liver macrophages consist of two major subsets: embryonic yolk sac&#8211;derived Kupffer cells (KCs) and monocyte&#8208;derived macrophages (MoDMs).<xref rid="ame270053-bib-0047" ref-type="bibr">
<sup>47</sup>
</xref> In healthy states, KCs constitute 80%&#8211;90% of hepatic macrophages and establish a specialized niche through pseudopod extensions that interface with parenchymal cells, including hepatic stellate cells, LSECs, and hepatocytes. These tissue&#8208;resident macrophages maintain immune surveillance via pattern recognition receptors (TLRs and scavenger receptors) and phagocytosis of pathogens/apoptotic debris.<xref rid="ame270053-bib-0048" ref-type="bibr">
<sup>48</sup>
</xref>, <xref rid="ame270053-bib-0049" ref-type="bibr">
<sup>49</sup>
</xref> As dominant antigen&#8208;presenting cells (APCs), KCs enforce immune tolerance by activating regulatory T cells (Tregs) while suppressing effector T&#8208;cell activation mediated by conventional APCs.<xref rid="ame270053-bib-0050" ref-type="bibr">
<sup>50</sup>
</xref> This tolerogenic function is reinforced during systemic exposure to low&#8208;dose particulate antigens, where KC&#8208;mediated antigen presentation induces CD4<sup>+</sup> T&#8208;cell anergy<xref rid="ame270053-bib-0051" ref-type="bibr">
<sup>51</sup>
</xref> and expands IL&#8208;10&#8208;producing populations,<xref rid="ame270053-bib-0052" ref-type="bibr">
<sup>52</sup>
</xref>, <xref rid="ame270053-bib-0053" ref-type="bibr">
<sup>53</sup>
</xref> leading to suppressed hepatic inflammation and establishment of tolerogenic immunity. By clearing pathogens (e.g., gram&#8208;positive bacteria) and senescent cells (e.g., erythrocytes, platelets), KCs reduce inflammatory triggers, thereby indirectly sustaining immune homeostasis.<xref rid="ame270053-bib-0054" ref-type="bibr">
<sup>54</sup>
</xref>, <xref rid="ame270053-bib-0055" ref-type="bibr">
<sup>55</sup>
</xref>
</p><p>Under pathological conditions such as liver fibrosis, KCs' functionality undergoes significant transformation. Niche alterations lead to loss of characteristic macrophage features and impaired bacterial surveillance in sinusoids. In response to persistent pathogen exposure, CD44&#8208;mediated recruitment of bone marrow&#8211;derived monocytes initiates the formation of KC&#8208;like syncytia within collateral vessels, which replenish the KC pool through CD36&#8208;dependent cellular adhesion and fusion mechanisms, restoring bacterial clearance capacity.<xref rid="ame270053-bib-0056" ref-type="bibr">
<sup>56</sup>
</xref>, <xref rid="ame270053-bib-0057" ref-type="bibr">
<sup>57</sup>
</xref> Damage&#8208;associated molecular patterns (DAMPs) activate KCs to adopt a pro&#8208;inflammatory phenotype, secreting CXCL2 (neutrophil chemoattractant), tumor necrosis factor &#945; (TNF&#8208;&#945;), and CCL2/CCL5, which drive neutrophil influx and monocyte recruitment, perpetuating fibrosis.<xref rid="ame270053-bib-0058" ref-type="bibr">
<sup>58</sup>
</xref>, <xref rid="ame270053-bib-0059" ref-type="bibr">
<sup>59</sup>
</xref> This chemokine amplification loop critically drives fibrotic progression through sustained monocyte infiltration.</p><p>Infiltrating monocytes differentiate into macrophages, the dominant pro&#8208;fibrotic population.<xref rid="ame270053-bib-0060" ref-type="bibr">
<sup>60</sup>
</xref> Guided by chemokines (CCL2, CX3CL1), these macrophages phagocytose cellular debris and mediate antigen presentation, linking innate and adaptive immunity.<xref rid="ame270053-bib-0061" ref-type="bibr">
<sup>61</sup>
</xref>, <xref rid="ame270053-bib-0062" ref-type="bibr">
<sup>62</sup>
</xref> Additionally, macrophages process and present antigens to T and B lymphocytes, bridging innate and adaptive immune responses. Their secretion of bioactive molecules&#8212;cytokines, chemokines, complement proteins, and enzymes&#8212;further modulates inflammatory and immune cascades.<xref rid="ame270053-bib-0061" ref-type="bibr">
<sup>61</sup>
</xref> Ly&#8208;6C<sup>+</sup> (mouse)/CD14<sup>+</sup> (human) monocytes are recruited to injury sites via CCL2, differentiating into pro&#8208;inflammatory macrophages.<xref rid="ame270053-bib-0063" ref-type="bibr">
<sup>63</sup>
</xref> These cells secrete TGF&#8208;&#946; and platelet&#8208;derived growth factor (PDGF) to directly activate hepatic stellate cells and synergize TNF&#8208;&#945;/IL&#8208;1&#946; with the NF&#8208;&#954;B&#8208;Smad axis to upregulate collagen synthesis.<xref rid="ame270053-bib-0064" ref-type="bibr">
<sup>64</sup>
</xref> PDGF activates ERK/PI3K&#8208;Akt pathways in hepatic stellate cells, promoting proliferation and migration. TGF&#8208;&#946;, the most potent pro&#8208;fibrotic cytokine, drives ECM deposition.<xref rid="ame270053-bib-0065" ref-type="bibr">
<sup>65</sup>
</xref>
</p><p>During resolution phases, Ly&#8208;6C<sup>lo</sup> monocytes or IL&#8208;4&#8208;polarized M2 macrophages dominate, degrading ECM via matrix metalloproteinases (MMPs). Mechanosensitive Piezo1 channels enhance efferocytosis and IL&#8208;10 secretion,<xref rid="ame270053-bib-0066" ref-type="bibr">
<sup>66</sup>
</xref> whereas STAT6&#8208;PPAR&#947; signaling mediates lipid metabolic reprogramming, fostering anti&#8208;inflammatory responses and matrix remodeling.<xref rid="ame270053-bib-0067" ref-type="bibr">
<sup>67</sup>
</xref>, <xref rid="ame270053-bib-0068" ref-type="bibr">
<sup>68</sup>
</xref>
</p><p>A specialized macrophage subset, termed lipid&#8208;associated macrophages (LAMs), critically modulates hepatic inflammation and fibrosis progression in fatty liver disease. In healthy livers, LAMs localize predominantly near bile ducts but dynamically accumulate in steatotic regions during metabolic dysfunction&#8208;associated steatotic liver disease (MASLD) or obesity.<xref rid="ame270053-bib-0069" ref-type="bibr">
<sup>69</sup>
</xref>, <xref rid="ame270053-bib-0070" ref-type="bibr">
<sup>70</sup>
</xref> Characterized by the expression of surface markers CD9<sup>+</sup>/TREM2<sup>+</sup>/CD36<sup>+</sup>, LAMs exhibit functional heterogeneity, transitioning between pro&#8208;inflammatory and tissue&#8208;reparative phenotypes depending on disease stage and microenvironmental cues.<xref rid="ame270053-bib-0071" ref-type="bibr">
<sup>71</sup>
</xref> Under pathological conditions such as MASLD and cirrhosis, LAMs primarily originate from CCR2<sup>+</sup>/CX3CR1<sup>+</sup> monocyte recruitment, driven by chemotactic signals from lipid&#8208;burdened hepatocytes and stromal cells.<xref rid="ame270053-bib-0072" ref-type="bibr">
<sup>72</sup>
</xref> Additionally, local proliferation of LAM precursors (e.g., Ms4a7<sup>+</sup> cells) and KC&#8208;mediated niche modulation further contribute to LAM pool expansion, with KC depletion impairing both recruitment and differentiation processes.<xref rid="ame270053-bib-0073" ref-type="bibr">
<sup>73</sup>
</xref>
</p><p>TREM2, a central regulator of LAM activity, governs lipid uptake, efferocytosis, and inflammatory modulation via pathways involving APOE and PPAR&#8208;&#947;.<xref rid="ame270053-bib-0071" ref-type="bibr">
<sup>71</sup>
</xref> Activation of TREM2 by sphingosine&#8208;1&#8208;phosphate (S1P), released from apoptotic hepatocytes, enhances efferocytotic clearance of lipid&#8208;laden debris, thereby mitigating lipotoxicity and preserving hepatic homeostasis.<xref rid="ame270053-bib-0074" ref-type="bibr">
<sup>74</sup>
</xref> Conversely, hepatocyte&#8208;derived ANGPTL8 interacts with the leukocyte receptor Pirab/LLRB2, promoting monocyte&#8208;to&#8208;LAM differentiation and amplifying pro&#8208;fibrotic signaling through collagen deposition and hepatic stellate cell activation.<xref rid="ame270053-bib-0075" ref-type="bibr">
<sup>75</sup>
</xref>
</p><p>Functional polarization of LAMs dictates their divergent roles in disease progression. During early metabolic dysfunction&#8208;associated steatohepatitis (MASH), CCR2<sup>+</sup> monocyte&#8208;derived LAMs secrete pro&#8208;inflammatory cytokines (e.g., TNF&#8208;&#945;, IL&#8208;1&#946;), exacerbating neutrophil infiltration and parenchymal injury.<xref rid="ame270053-bib-0070" ref-type="bibr">
<sup>70</sup>
</xref> In advanced stages, scar&#8208;associated macrophages (SAMs), a LAM subset marked by elevated SPP1 (osteopontin) expression, drive fibrosis by activating hepatic stellate cells and depositing ECM components.<xref rid="ame270053-bib-0076" ref-type="bibr">
<sup>76</sup>
</xref>, <xref rid="ame270053-bib-0077" ref-type="bibr">
<sup>77</sup>
</xref> Trem2<sup>+</sup> LAMs also regulate hepatocyte lipid metabolism through mitochondrial pathways, such as the miR&#8208;106b&#8208;5p&#8208;Mfn2 axis, which attenuates steatosis by enhancing mitochondrial fusion and lipid oxidation.<xref rid="ame270053-bib-0078" ref-type="bibr">
<sup>78</sup>
</xref> These findings underscore LAMs as pivotal regulators of hepatic inflammation resolution and fibrotic remodeling, highlighting their potential as therapeutic targets in metabolic liver diseases.</p></sec><sec id="ame270053-sec-0009"><label>2.2.2</label><title>Neutrophils</title><p>Constituting 1%&#8211;2% of circulating immune cells under homeostasis, are rapidly mobilized postinjury via G&#8208;CSF/GM&#8208;CSF.<xref rid="ame270053-bib-0079" ref-type="bibr">
<sup>79</sup>
</xref>, <xref rid="ame270053-bib-0080" ref-type="bibr">
<sup>80</sup>
</xref> Activation mechanisms involve pattern recognition through TLR2/9, immunoglobulin Fc receptors, and complement system components.<xref rid="ame270053-bib-0081" ref-type="bibr">
<sup>81</sup>
</xref>, <xref rid="ame270053-bib-0082" ref-type="bibr">
<sup>82</sup>
</xref> Neutrophils eliminate pathogens via three principal effector mechanisms: phagocytic engulfment, reactive oxygen species generation, and neutrophil extracellular trap (NET) formation.<xref rid="ame270053-bib-0033" ref-type="bibr">
<sup>33</sup>
</xref>, <xref rid="ame270053-bib-0083" ref-type="bibr">
<sup>83</sup>
</xref>, <xref rid="ame270053-bib-0084" ref-type="bibr">
<sup>84</sup>
</xref> Notably, NET components, including DNA&#8208;protein complexes, granular enzymes (myeloperoxidase, neutrophil elastase, MMP&#8208;9), and modified histones, demonstrate pro&#8208;fibrotic potential. Mechanistic studies reveal that hepatic stellate cell activation occurs through dual signaling cascades: TLR9&#8208;mediated NF&#8208;&#954;B activation and TGF&#8208;&#946;&#8208;dependent Smad phosphorylation, ultimately facilitating ECM remodeling.<xref rid="ame270053-bib-0085" ref-type="bibr">
<sup>85</sup>
</xref> The pathological effects are amplified through histone&#8208;induced TLR4/MyD88 signal transduction and NET&#8208;derived chemotactic factors (CXCL1/CXCL8), which establish a self&#8208;perpetuating inflammatory microenvironment conducive to sustained fibrogenic processes.<xref rid="ame270053-bib-0086" ref-type="bibr">
<sup>86</sup>
</xref>
</p></sec><sec id="ame270053-sec-0010"><label>2.2.3</label><title>Eosinophils</title><p>Eosinophils, traditionally associated with antiparasitic immunity and allergic responses,<xref rid="ame270053-bib-0087" ref-type="bibr">
<sup>87</sup>
</xref> are increasingly recognized for their regulatory roles in inflammation resolution and tissue repair. IL&#8208;33 released by damaged sinusoidal endothelial cells activates eosinophils, which secrete CCL24 to recruit additional eosinophils via a feedforward loop.<xref rid="ame270053-bib-0088" ref-type="bibr">
<sup>88</sup>
</xref>, <xref rid="ame270053-bib-0089" ref-type="bibr">
<sup>89</sup>
</xref> Activated eosinophils mitigate excessive inflammation by suppressing IFN&#8208;&#947; via IL&#8208;4/IL&#8208;13 and promote repair through heparin&#8208;binding epidermal growth factor (HB&#8208;EGF) release from macrophages, mediated by p38&#8208;COX&#8208;NF&#8208;&#954;B signaling.<xref rid="ame270053-bib-0090" ref-type="bibr">
<sup>90</sup>
</xref> This dual functionality underscores eosinophils as emerging modulators of hepatic inflammation resolution and regenerative processes.</p></sec><sec id="ame270053-sec-0011"><label>2.2.4</label><title>Dentritic cells</title><p>As specialized APCs, DCs execute critical immunological functions encompassing antigen capture, processing, and presentation, coupled with lymphoid organ homing and cytokine&#8208;mediated coordination of innate/adaptive immunity.<xref rid="ame270053-bib-0091" ref-type="bibr">
<sup>91</sup>
</xref>, <xref rid="ame270053-bib-0092" ref-type="bibr">
<sup>92</sup>
</xref> Hepatic DCs (LDCs) under homeostatic conditions maintain an immunotolerant phenotype characterized by functional immaturity.<xref rid="ame270053-bib-0093" ref-type="bibr">
<sup>93</sup>
</xref> During liver injury, DC precursors expand locally under the stimulation of GM&#8208;CSF or FLT3L, whereas circulating DCs may also replenish the hepatic DC pool.<xref rid="ame270053-bib-0094" ref-type="bibr">
<sup>94</sup>
</xref>, <xref rid="ame270053-bib-0095" ref-type="bibr">
<sup>95</sup>
</xref>, <xref rid="ame270053-bib-0096" ref-type="bibr">
<sup>96</sup>
</xref> In chronic liver injury, pro&#8208;inflammatory LDCs dominate, promoting fibrosis by secreting IL&#8208;6 and TNF&#8208;&#945;, which activate hepatic stellate cells and drive collagen deposition.<xref rid="ame270053-bib-0097" ref-type="bibr">
<sup>97</sup>
</xref> Contrastingly, acute injury induces protective LDC subpopulations that mitigate tissue damage through neutrophil apoptosis regulation, effectively attenuating parenchymal necrosis. Current research limitations stem from overlapping phenotypic markers with monocyte&#8208;derived cells and context&#8208;dependent plasticity, necessitating advanced single&#8208;cell analyses to delineate precise regulatory mechanisms in hepatic fibrogenesis.</p></sec><sec id="ame270053-sec-0012"><label>2.2.5</label><title>Mast cell and basophils</title><p>Although MCs and basophils represent a minor population among hepatic immune cells, they play significant roles in liver pathological processes. MCs are closely associated with cholangiocyte injury, as cholangiocyte&#8208;derived insulin&#8208;like growth factor&#8208;1 (IGF&#8208;1) promotes MC migration to the liver, where they accumulate around damaged bile ducts and release histamine, thereby inducing ductular reaction (DR), cholestasis, and liver fibrosis.<xref rid="ame270053-bib-0098" ref-type="bibr">
<sup>98</sup>
</xref> MCs directly activate hepatic stellate cells by releasing histamine, tryptase, and TGF&#8208;&#946;1, driving their transdifferentiation into myofibroblasts. Furthermore, MCs exacerbate the fibrotic microenvironment through vascular endothelial growth factor (VEGF)&#8208; and fibroblast growth factor&#8208;2 (FGF&#8208;2)&#8208;mediated sinusoidal capillarization.<xref rid="ame270053-bib-0099" ref-type="bibr">
<sup>99</sup>
</xref> Basophils primarily participate in type 2 immune responses by producing IL&#8208;4 and IL&#8208;13, which promote hepatic stellate cell activation and collagen synthesis.<xref rid="ame270053-bib-0100" ref-type="bibr">
<sup>100</sup>
</xref> Additionally, basophils recognize IgE&#8208;antigen complexes via Fc&#949;RI, triggering the release of pro&#8208;inflammatory mediators such as histamine and LTB4, thereby aggravating liver injury.<xref rid="ame270053-bib-0101" ref-type="bibr">
<sup>101</sup>
</xref>
</p><p>Emerging evidence reveals that hepatic macrophages originating from bone marrow progenitor cells undergo functional specialization in response to local tissue signals, demonstrating remarkable adaptability through their capacity to adopt distinct activation states characterized as pro&#8208;inflammatory (M1) or immunoregulatory (M2) populations.<xref rid="ame270053-bib-0102" ref-type="bibr">
<sup>102</sup>
</xref> The M2 phenotype displays additional heterogeneity with four recognized subtypes (M2a&#8211;d), each demonstrating unique functional characteristics.<xref rid="ame270053-bib-0103" ref-type="bibr">
<sup>103</sup>
</xref>
</p><p>Macrophage polarization dichotomy is fundamentally regulated by differential arginine processing pathways: classically activated M1 macrophages preferentially express inducible nitric oxide synthase (iNOS) to catalyze the conversion of arginine into citruttine and nitric oxide, whereas alternatively activated M2 macrophages predominantly use arginase&#8208;1 (Arg1) to metabolize arginine into ornithine and urea.<xref rid="ame270053-bib-0104" ref-type="bibr">
<sup>104</sup>
</xref> This metabolic divergence establishes arginase pathway modulation as a promising therapeutic target for macrophage functional reprogramming.</p><p>Cellular bioenergetic pathways significantly influence inflammatory programming, with M1 macrophages demonstrating glycolytic dependency compared to the oxidative phosphorylation (OXPHOS) preference of M2 phenotypes.<xref rid="ame270053-bib-0105" ref-type="bibr">
<sup>105</sup>
</xref> Metabolic pathway switching has been shown to mediate phenotypic interconversion, as evidenced by reduced pro&#8208;inflammatory cytokine production following glycolytic inhibition. The glycolytic master regulator HIF&#8208;1&#945; not only enhances glycolytic flux and pentose phosphate pathway activity but also promotes M1 polarization.<xref rid="ame270053-bib-0106" ref-type="bibr">
<sup>106</sup>
</xref>, <xref rid="ame270053-bib-0107" ref-type="bibr">
<sup>107</sup>
</xref>, <xref rid="ame270053-bib-0108" ref-type="bibr">
<sup>108</sup>
</xref> Its activation is modulated by multiple metabolic signals, including TCA cycle intermediates (succinate/citrate), mechanistic target of rapamycin complex (mTORC1)&#160;signaling, and pyruvate kinase M2 (PKM2) activity.<xref rid="ame270053-bib-0109" ref-type="bibr">
<sup>109</sup>
</xref>, <xref rid="ame270053-bib-0110" ref-type="bibr">
<sup>110</sup>
</xref>, <xref rid="ame270053-bib-0111" ref-type="bibr">
<sup>111</sup>
</xref> Interestingly, neutrophil&#8208;derived oxidative stress can induce AMPK activation in macrophages, inhibiting mTOR&#8208;mediated signaling to facilitate metabolic shift from glycolytic M1 toward OXPHOS&#8208;dependent M2 states.<xref rid="ame270053-bib-0112" ref-type="bibr">
<sup>112</sup>
</xref>
</p><p>Lipid metabolic reprogramming exerts bidirectional effects on macrophage polarization. Although M2 polarization associates with PPAR&#8208;mediated fatty acid oxidation (FAO) potentiation through RIPK3 signaling, FAO inhibition fails to completely reverse M2 characteristics, suggesting compensatory mechanisms.<xref rid="ame270053-bib-0113" ref-type="bibr">
<sup>113</sup>
</xref>, <xref rid="ame270053-bib-0114" ref-type="bibr">
<sup>114</sup>
</xref> Paradoxically, FAO can trigger inflammasome activation in M1 macrophages, highlighting context&#8208;dependent effects. Lipid synthesis, conversely, correlates with pro&#8208;inflammatory responses.<xref rid="ame270053-bib-0114" ref-type="bibr">
<sup>114</sup>
</xref>, <xref rid="ame270053-bib-0115" ref-type="bibr">
<sup>115</sup>
</xref>, <xref rid="ame270053-bib-0116" ref-type="bibr">
<sup>116</sup>
</xref> Inhibiting lipid synthesis while enhancing catabolism promotes M2 polarization and alleviates inflammation.<xref rid="ame270053-bib-0117" ref-type="bibr">
<sup>117</sup>
</xref>, <xref rid="ame270053-bib-0118" ref-type="bibr">
<sup>118</sup>
</xref> The mTORC1&#8208;SREBP&#8208;1a axis maintains crucial phagocytic functions through regulated lipid synthesis, illustrating the dual regulatory roles of lipid metabolism in macrophage biology.<xref rid="ame270053-bib-0119" ref-type="bibr">
<sup>119</sup>
</xref>, <xref rid="ame270053-bib-0120" ref-type="bibr">
<sup>120</sup>
</xref>
</p><p>Amino acid handling further contributes to polarization dynamics, where glutamine metabolism supports M2 activation via &#945;&#8208;ketoglutarate&#8208;mediated epigenetic regulation and FAO induction.<xref rid="ame270053-bib-0121" ref-type="bibr">
<sup>121</sup>
</xref> Glutamine&#8208;depleted microenvironments trigger compensatory glutamine synthetase upregulation, though the functional consequences require further investigation. Serine metabolic pathways exhibit context&#8208;dependent regulation, supporting M1&#8208;associated IL&#8208;1&#946; production through phosphoglycerate dehydrogenase signaling and NLRP3 inflammasome activation.<xref rid="ame270053-bib-0122" ref-type="bibr">
<sup>122</sup>
</xref>, <xref rid="ame270053-bib-0123" ref-type="bibr">
<sup>123</sup>
</xref> Serine synthesis inhibition shifts macrophages toward M1 polarization via JAK/STAT signaling, whereas its upregulation promotes M2 phenotypes.<xref rid="ame270053-bib-0124" ref-type="bibr">
<sup>124</sup>
</xref>, <xref rid="ame270053-bib-0125" ref-type="bibr">
<sup>125</sup>
</xref> However, serine metabolism's role in inflammasome activation remains context&#8208;specific.</p><p>This metabolic network complexity underscores the intricate relationship between nutrient utilization and immune cell function, suggesting therapeutic potential in targeting key metabolic nodes (glycolysis, FAO, amino acid pathways) to rebalance inflammatory and reparative responses in hepatic pathophysiology and systemic inflammatory disorders.</p><p>Within the inflammatory milieu, KC&#8208;derived IL&#8208;6 initiates paracrine signaling through IL&#8208;6 receptor/gp130 complexes on neighboring hepatocytes and macrophages, triggering STAT3 activation that orchestrates dual biological processes.<xref rid="ame270053-bib-0126" ref-type="bibr">
<sup>126</sup>
</xref>, <xref rid="ame270053-bib-0127" ref-type="bibr">
<sup>127</sup>
</xref> STAT3 drives hepatocyte dedifferentiation to support regeneration<xref rid="ame270053-bib-0128" ref-type="bibr">
<sup>128</sup>
</xref> and regulates macrophage polarization by suppressing the pro&#8208;inflammatory Ly&#8208;6C<sup>hi</sup> phenotype while promoting the generation of reparative Ly&#8208;6C<sup>lo</sup>macrophages.<xref rid="ame270053-bib-0129" ref-type="bibr">
<sup>129</sup>
</xref> During distinct phases of injury, STAT3 and STAT6 exhibit stage&#8208;specific synergy: STAT3 responds to early inflammatory signals, whereas STAT6 mediates M2 polarization in later stages, collectively inhibiting Ly6C<sup>hi</sup> monocyte activity and fostering tissue repair.<xref rid="ame270053-bib-0130" ref-type="bibr">
<sup>130</sup>
</xref>, <xref rid="ame270053-bib-0131" ref-type="bibr">
<sup>131</sup>
</xref> Concurrently, TGF&#8208;&#946; signals through Smad2/3 in the resolution phase to induce M2 macrophage polarization and suppress Ly&#8208;6C<sup>hi</sup> monocyte recruitment, thereby attenuating inflammation and promoting fibrosis regression.<xref rid="ame270053-bib-0132" ref-type="bibr">
<sup>132</sup>
</xref>, <xref rid="ame270053-bib-0133" ref-type="bibr">
<sup>133</sup>
</xref>, <xref rid="ame270053-bib-0134" ref-type="bibr">
<sup>134</sup>
</xref> The transcription factors IRF4 and PPAR&#947; form a complex that amplifies M2&#8208;associated gene transcription and restrains the inflammatory activity of Ly&#8208;6C<sup>hi</sup> monocytes, further enhancing reparative responses.<xref rid="ame270053-bib-0135" ref-type="bibr">
<sup>135</sup>
</xref>, <xref rid="ame270053-bib-0136" ref-type="bibr">
<sup>136</sup>
</xref> Th2 cytokine signaling through IL&#8208;4/IL&#8208;13&#8208;STAT6 axes further stabilizes M2 polarization states.<xref rid="ame270053-bib-0137" ref-type="bibr">
<sup>137</sup>
</xref>
</p><p>Chromatin dynamics and epigenetic modifications fundamentally regulate macrophage functional adaptation in disease contexts. Nutritional stress in NASH pathogenesis induces AP&#8208;1/EGR&#8208;mediated enhancer landscape reorganization in KCs, disrupting LXR&#8208;dependent homeostatic programming and triggering phenotypic conversion marked by Trem2/CD9 overexpression, ultimately resulting in KC depletion and monocyte&#8208;derived macrophage infiltration.<xref rid="ame270053-bib-0138" ref-type="bibr">
<sup>138</sup>
</xref> These recruited macrophages demonstrate fibrotic niche&#8208;adapted epigenomic signatures through convergent chromatin accessibility patterns. Mechanistic studies reveal STAT3 cooperates with chromatin modifier Arid1a to engage H3K27ac&#8208;marked regulatory elements, activating tissue&#8208;repair enhancers (e.g., Arg1/Ym1) while silencing Ly&#8208;6C<sup>hi</sup>&#8208;associated inflammatory loci.<xref rid="ame270053-bib-0139" ref-type="bibr">
<sup>139</sup>
</xref>, <xref rid="ame270053-bib-0140" ref-type="bibr">
<sup>140</sup>
</xref>, <xref rid="ame270053-bib-0141" ref-type="bibr">
<sup>141</sup>
</xref> DNA methylation dynamics also contribute to phenotype regulation, with DNA demethylases like TET2 potentially modulating macrophage plasticity during tissue repair, though mechanistic details remain to be elucidated.<xref rid="ame270053-bib-0142" ref-type="bibr">
<sup>142</sup>
</xref>, <xref rid="ame270053-bib-0143" ref-type="bibr">
<sup>143</sup>
</xref>
</p><p>This integrated signaling&#8208;epigenetic axis underscores the adaptability of hepatic macrophages to microenvironmental cues, balancing inflammatory resolution and regenerative responses in liver pathophysiology. We have schematically depicted the recruitment of myeloid cells to the liver under pathological conditions and their specific mechanisms in promoting both the progression and regression of hepatic fibrosis, as detailed in Figure&#160;<xref rid="ame270053-fig-0002" ref-type="fig">2</xref>.</p><fig position="float" fig-type="FIGURE" id="ame270053-fig-0002" orientation="portrait"><label>FIGURE 2</label><caption><p>Mechanisms of myeloid cells in liver fibrosis progression. Myeloid bias in hematopoietic stem cells, damage&#8208;associated molecular patterns (DAMPs) released by injured hepatocytes and cholangiocytes, and gut&#8208;derived pathogen&#8208;associated molecular patterns (PAMPs, e.g., LPS) collectively drive alterations in the hepatic immune microenvironment. DAMPs and PAMPs activate Kupffer cells to initiate inflammatory responses. Kupffer cells and hepatic stellate cells jointly secrete factors that recruit Ly&#8208;6C<sup>hi</sup> monocytes and neutrophils. These pro&#8208;inflammatory myeloid cells secrete cytokines within the liver microenvironment, further activating hepatic stellate cells and promoting collagen deposition. During fibrosis resolution, Ly&#8208;6C<sup>lo</sup> monocyte&#8208;derived macrophages facilitate collagen degradation and induce apoptosis of activated hepatic stellate cells.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-5" orientation="portrait" xlink:href="AME2-8-1215-g001.jpg"/></fig></sec></sec></sec><sec id="ame270053-sec-0013"><label>3</label><title>THERAPEUTIC STRATEGIES TARGETING MYELOID CELLS</title><p>Targeted therapeutic approaches for liver fibrosis based on molecular mechanisms can be broadly categorized into three strategies: inhibition of myeloid cell production and recruitment, suppression of myeloid cell&#8208;related pro&#8208;fibrotic signaling cascades, and macrophage phenotype reprogramming.</p><sec id="ame270053-sec-0014"><label>3.1</label><title>Targeting myeloid&#8208;biased hematopoiesis</title><p>The myeloid skewing of aged HSCs (my&#8208;HSCs) represents a fundamental driver of age&#8208;related hepatic fibrosis, positioning the targeting of myeloid differentiation a potential upstream approach for modulating the liver's immune microenvironment. Age&#8208;associated DNMT3A dysfunction, a critical DNA methyltransferase responsible for silencing inflammatory genes, exacerbates myeloid&#8208;mediated hepatic pathology. The loss of DNMT3A activity leads to derepression of pro&#8208;inflammatory genes (e.g., IL&#8208;1&#945;), thereby amplifying hepatic inflammatory responses and accelerating fibrotic progression. Pharmacological strategies aimed at restoring DNMT3A function could potentially rebalance hematopoietic output by epigenetically suppressing IL&#8208;1&#945; overproduction, thereby interrupting the self&#8208;perpetuating cycle of inflammation&#8208;driven fibrosis.<xref rid="ame270053-bib-0023" ref-type="bibr">
<sup>23</sup>
</xref> Recent investigations have demonstrated that Oridonin inhibits DNMT3A R882 mutation&#8208;driven clonal hematopoiesis and leukemia by inducing apoptosis and necroptosis, suggesting its potential therapeutic value for ameliorating myeloid skewing&#8208;related peripheral organ pathologies. Furthermore, emerging evidence indicates that selective elimination of my&#8208;HSCs by targeting surface antigen combinations (CD150/NEO1/CD41/CD62p) can effectively restrict the generation of pro&#8208;inflammatory myeloid cells while promoting lymphopoiesis, consequently enhancing immune competence in aged hosts.<xref rid="ame270053-bib-0144" ref-type="bibr">
<sup>144</sup>
</xref> Therapeutic modulation of the hematopoietic differentiation trajectory, either through inhibition of inflammation&#8208;induced NF&#8208;&#954;B hyperactivity or by rebalancing key transcription factors (upregulating lymphoid factor Ikzf1 while suppressing myeloid determinant Cebpa), may offer potential for reversing myeloid bias at its origin. Although clinically effective pharmaceuticals targeting myeloid skewing remain to be developed, this approach holds considerable therapeutic promise for age&#8208;related fibrotic disorders.</p></sec><sec id="ame270053-sec-0015"><label>3.2</label><title>Inhibition of myeloid cell recruitment</title><p>The recruitment of inflammatory monocytes can be attenuated by targeting key chemokine pathways such as CCL2&#8208;CCR2, CCL1&#8208;CCR8, and CXCL10&#8208;CXCR3. Monoclonal antibodies against these chemokines or their receptors effectively block signal transduction, thereby preventing monocyte infiltration into the liver.<xref rid="ame270053-bib-0145" ref-type="bibr">
<sup>145</sup>
</xref> For instance, the CCR2/CCR5 dual antagonist Cenicriviroc (CVC) has demonstrated efficacy in ameliorating liver fibrosis in patients with nonalcoholic steatohepatitis.<xref rid="ame270053-bib-0146" ref-type="bibr">
<sup>146</sup>
</xref>, <xref rid="ame270053-bib-0147" ref-type="bibr">
<sup>147</sup>
</xref> Similarly, inhibition of G&#8208;CSF suppresses neutrophil differentiation in bone marrow, subsequently reducing inflammatory responses.<xref rid="ame270053-bib-0148" ref-type="bibr">
<sup>148</sup>
</xref>, <xref rid="ame270053-bib-0149" ref-type="bibr">
<sup>149</sup>
</xref> Certain compounds, such as curcumin, exert indirect effects by attenuating KC activation and subsequent chemokine secretion, leading to decreased Ly&#8208;6C<sup>hi</sup> monocyte infiltration and prevention of hepatic fibrosis.<xref rid="ame270053-bib-0150" ref-type="bibr">
<sup>150</sup>
</xref>, <xref rid="ame270053-bib-0151" ref-type="bibr">
<sup>151</sup>
</xref> Additionally, reversing myeloid bias in HSCs represents a potential therapeutic target, which may concurrently exert antiaging and antifibrotic effects. However, no clinical studies have yet investigated this approach for treating liver fibrosis.</p></sec><sec id="ame270053-sec-0016"><label>3.3</label><title>Suppression of myeloid cell&#8208;mediated profibrotic signaling</title><p>The TGF&#8208;&#946; pathway represents a critical therapeutic target, as it serves as both a key activator of hepatic stellate cells and a mediator of systemic aging through macrophage signaling.<xref rid="ame270053-bib-0014" ref-type="bibr">
<sup>14</sup>
</xref> TGF&#8208;&#946; inhibition significantly reduces expression of fibrotic markers, including TIMP&#8208;1, collagen types I/IV, &#945;&#8208;SMA, and endothelin&#8208;1.<xref rid="ame270053-bib-0152" ref-type="bibr">
<sup>152</sup>
</xref> Anti&#8208;inflammatory cytokine antagonists, particularly anti&#8208;TNF&#8208;&#945; monoclonal antibodies (e.g., infliximab) and IL&#8208;1 receptor antagonists (e.g., anakinra), show potential in reversing hepatic stellate cell activation. Preclinical studies have revealed context&#8208;dependent efficacy of IL&#8208;1&#946; antagonism, which reduces hepatic stellate cell proliferation in&#160;vitro.<xref rid="ame270053-bib-0153" ref-type="bibr">
<sup>153</sup>
</xref> Enhancement of IL&#8208;10 signaling exerts dual therapeutic effects through coordinated immunomodulatory mechanisms. Mechanistically, IL&#8208;10 elevation drives macrophage phenotypic switching toward restorative M2&#8208;like polarization while simultaneously inducing senescence in activated hepatic stellate cells via paracrine regulation, simultaneously decelerating fibrogenesis and promoting tissue repair.<xref rid="ame270053-bib-0154" ref-type="bibr">
<sup>154</sup>
</xref>, <xref rid="ame270053-bib-0155" ref-type="bibr">
<sup>155</sup>
</xref> These findings underscore the multifactorial nature of fibrosis treatment, which requires integration of regenerative, immunomodulatory, and direct antifibrotic strategies while balancing efficacy, safety, and translational potential.<xref rid="ame270053-bib-0156" ref-type="bibr">
<sup>156</sup>
</xref>, <xref rid="ame270053-bib-0157" ref-type="bibr">
<sup>157</sup>
</xref>
</p><p>Macrophage polarization offers another promising therapeutic avenue due to the functional plasticity of these cells, with MSC therapies from diverse tissue sources showing clinical promise.<xref rid="ame270053-bib-0158" ref-type="bibr">
<sup>158</sup>
</xref> MSC mechanisms encompass secretome&#8208;mediated hepatocyte regeneration via IGF&#8208;1/PI3K/AKT/&#946;&#8208;catenin axis activation and sinusoidal endothelial repair through VEGF&#8208;A/Flt1&#8208;HB&#8208;EGF/HGF cross talk.<xref rid="ame270053-bib-0159" ref-type="bibr">
<sup>159</sup>
</xref>, <xref rid="ame270053-bib-0160" ref-type="bibr">
<sup>160</sup>
</xref> Additionally, MSC&#8208;mediated immunomodulation through IL&#8208;4 and IL&#8208;10 secretion promotes macrophage polarization from pro&#8208;fibrotic Ly&#8208;6C<sup>hi</sup> to pro&#8208;resolving Ly&#8208;6C<sup>lo</sup> phenotypes, thereby suppressing production of TGF&#8208;&#946;, PDGF, TNF&#8208;&#945;, and IL&#8208;1&#946;. This phenotypic switch effectively inhibits hepatic stellate cell activation and reduces oxidative stress. In murine models of liver fibrosis, splenectomy has been shown to promote ERK1/2 phosphorylation in macrophages, facilitating their conversion to the Ly&#8208;6C<sup>lo</sup> phenotype and subsequently ameliorating hepatic inflammation and fibrosis. Clinical investigations are currently exploring the therapeutic potential of autologous monocyte&#8208;derived macrophages that have been ex&#160;vivo polarized toward a reparative phenotype for liver fibrosis treatment.<xref rid="ame270053-bib-0161" ref-type="bibr">
<sup>161</sup>
</xref>, <xref rid="ame270053-bib-0162" ref-type="bibr">
<sup>162</sup>
</xref> Further therapeutic options are systematically summarized in Table&#160;<xref rid="ame270053-tbl-0002" ref-type="table">2</xref>.</p><table-wrap position="float" id="ame270053-tbl-0002" content-type="TABLE" orientation="portrait"><label>TABLE 2</label><caption><p>Potential therapy targeting myeloid cells in liver fibrosis.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Target/pathway</th><th align="left" valign="bottom" rowspan="1" colspan="1">Drug/intervention</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Myeloid bias</td><td align="left" valign="top" rowspan="1" colspan="1">Surface antigen combinations (CD150/NEO1/CD41/CD62p) (preclinical)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">DNMT3A</td><td align="left" valign="top" rowspan="1" colspan="1">Oridonin (preclinical)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CCR2/CCR5 antagonist</td><td align="left" valign="top" rowspan="1" colspan="1">
<p>Cenicriviroc mesylate (phase 3)</p>
<p>Gemcabene calcium (phase 2)</p>
<p>WXSH&#8208;0213 (preclinical)</p>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">G&#8208;CSF/GM&#8208;CSF</td><td align="left" valign="top" rowspan="1" colspan="1">
<p>Talimogene laherparepvec (approved for listing)</p>
<p>Pexastimogene devacirepvec (phase 3)</p>
<p>BS 001 (phase 3)</p>
<p>ORIENX 010 (phase 2)</p>
<p>SYNOV1.1 (phase 1)</p>
<p>mSJ 650 (preclinical)</p>
<p><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:clinical-trial" xlink:href="NCT03415698">NCT03415698</ext-link></p>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">TLR4/NF&#8208;&#954;B signaling, CCL2 secretion</td><td align="left" valign="top" rowspan="1" colspan="1">Curcumin (phase 2)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">TGF&#8208;&#946;/Smad pathway</td><td align="left" valign="top" rowspan="1" colspan="1">Fresolimumab (phase 2)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">TNF&#8208;&#945; antagonist</td><td align="left" valign="top" rowspan="1" colspan="1">
<p>Infliximab (approved for listing)</p>
<p>WO2023147029 (preclinical)</p>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">IL&#8208;1R antagonist</td><td align="left" valign="top" rowspan="1" colspan="1">
<p>CUD 005 (phase 1)</p>
<p>Anakinra (approved for listing)</p>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">IL&#8208;4&#8208;IL&#8208;13R antagonist</td><td align="left" valign="top" rowspan="1" colspan="1">Stapokibart (approved for listing)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">IL&#8208;11R antagonist</td><td align="left" valign="top" rowspan="1" colspan="1">
<p>Interleukin 11 antagonist (Boehringer Ingelheim) (preclinical)</p>
<p>LASN&#8208;01 (phase 2)</p>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">LPAR1 antagonist</td><td align="left" valign="top" rowspan="1" colspan="1">Admilparant (phase 3)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PDGFR modulator</td><td align="left" valign="top" rowspan="1" colspan="1">
<p>BOT&#8208;191 (preclinical)</p>
<p>ATH&#8208;001 (preclinical)</p>
<p>KBP&#8208;7018 (preclinical)</p>
<p>68Ga&#8208;BOT1712 (preclinical)</p>
<p>Sorafenib Tosylate (approved for listing)</p>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">TLR4/MyD88 inhibitor</td><td align="left" valign="top" rowspan="1" colspan="1">Resatorvid (preclinical)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">LOXL2 inhibitor</td><td align="left" valign="top" rowspan="1" colspan="1">Simtuzumab (phase 3)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Macrophage polarization (mesenchymal stem cells)</td><td align="left" valign="top" rowspan="1" colspan="1">
<p>MSCs from allogeneic bone marrow (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:clinical-trial" xlink:href="NCT01741090">NCT01741090</ext-link>)</p>
<p>MSCs from autologous adipose (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:clinical-trial" xlink:href="NCT02297867">NCT02297867</ext-link>)</p>
<p>MSCs from menstrual blood (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:clinical-trial" xlink:href="NCT01483248">NCT01483248</ext-link>)</p>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Stem cell therapy</td><td align="left" valign="top" rowspan="1" colspan="1">
<p>Bone marrow&#8211;derived mononuclear cells and CD133<sup>+</sup> cells (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:clinical-trial" xlink:href="NCT01120925">NCT01120925</ext-link>)</p>
<p>Autologous CD34<sup>+</sup>stem cells</p>
<p>(<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:clinical-trial" xlink:href="NCT00147043">NCT00147043</ext-link>)</p>
</td></tr></tbody></table><table-wrap-foot id="ame270053-ntgp-0002"><fn id="ame270053-note-0002"><p>Abbreviations: G&#8208;CSF/GM&#8208;CSF, granulocyte colony&#8208;stimulating factor/granulocyte&#8208;macrophage colony&#8208;stimulating factor; IL, interleukin; NF&#8208;&#954;B, nuclear factor kappa B; PDGFR, platelet&#8208;derived growth factor receptor; TGF&#8208;&#946;, transforming growth factor &#946;; TLR, toll&#8208;like receptor; TNF&#8208;&#945;, tumor necrosis factor &#945;.</p></fn></table-wrap-foot></table-wrap></sec></sec><sec id="ame270053-sec-0017"><label>4</label><title>CONCLUSIONS AND PERSPECTIVES</title><p>We summarize current knowledge on liver myeloid cells, including their origins, recruitment, and functional roles in both physiological and fibrotic conditions. We highlight key regulatory mechanisms governing myeloid cell behavior and discuss their implications for liver fibrosis progression.</p><p>Current therapeutic strategies primarily focus on three approaches: blocking pathological myeloid recruitment via chemokine axis targeting, correcting myeloid dysfunction through small&#8208;molecule inhibitors of key signaling pathways (TGF&#8208;&#946;/STAT3/IL&#8208;6), and rebalancing macrophage polarization via stem cell therapies or epigenetic editing. Although MSC&#8208;based therapies show promise in modulating macrophage phenotypes and enhancing matrix degradation, clinical translation remains limited by challenges in cellular homing efficiency and functional persistence. Several targeted agents against pro&#8208;fibrotic myeloid pathways have entered phase 2/3 trials, showing 20%&#8211;35% reduction in hepatic collagen content compared to placebo. However, the interconnected nature of fibroinflammatory signaling networks necessitates stage&#8208;specific therapeutic selection. For instance, early&#8208;stage patients (F0&#8211;F2) may benefit more from CCR2 blockade, whereas advanced fibrosis (F3&#8211;F4) might require combinatorial TGF&#8208;&#946;/STAT3 inhibition. The specific antifibrotic efficacy of therapeutic agents targeting distinct molecular pathways remains to be rigorously validated through additional clinical trials. Despite promising preclinical findings regarding their mechanisms of action in hepatic fibrosis resolution, the clinical translation of these targeted therapies requires comprehensive verification in well&#8208;designed multicenter studies with standardized endpoints.</p><p>Especially, accumulating evidence suggests that HSC myeloid skewing represents a fundamental cause of immune dysregulation in liver fibrosis. The myeloid bias of senescent HSCs leads to a decline in the body's anti&#8208;inflammatory capacity, resulting in increased susceptibility to peripheral organ damage and a state of persistent chronic inflammation. Consequently, aging is frequently associated with elevated incidence and mortality rates of various chronic diseases, including liver fibrosis. Recent studies have demonstrated that targeted clearance of senescent hematopoietic cells can reverse systemic aging, wherein the proportion of myeloid cells within the immune microenvironment plays a pivotal regulatory role.<xref rid="ame270053-bib-0144" ref-type="bibr">
<sup>144</sup>
</xref>, <xref rid="ame270053-bib-0163" ref-type="bibr">
<sup>163</sup>
</xref> Preclinical models demonstrate that genetic ablation of myeloid transcription factors (e.g., PU.1 knockdown) reduces liver collagen deposition.<xref rid="ame270053-bib-0035" ref-type="bibr">
<sup>35</sup>
</xref> This underscores the therapeutic potential of intercepting myeloid differentiation trajectories during early liver injury. Clinically, the established association between clonal hematopoiesis (CHIP mutations: DNMT3A, TET2) and increased cirrhosis risk warrants enhanced surveillance of liver pathology in hematologic disorders.<xref rid="ame270053-bib-0026" ref-type="bibr">
<sup>26</sup>
</xref> By fundamentally reprogramming the hepatic immune niche through precision targeting of myeloid ontogeny, these strategies offer transformative potential to concurrently halt fibrotic progression and restore immune homeostasis.</p><p>In conclusion, the myeloid&#8208;biased differentiation trajectory of HSCs has emerged as a critical pathogenic determinant in hepatic fibrogenesis. Targeting the upstream dysregulation in HSC lineage commitment may enable immunomodulatory reprogramming of the hepatic niche, thereby disrupting the pro&#8208;fibrotic cascade at its origin. Preclinical studies indicate that restoring balanced myeloid&#8208;lymphoid output through HSC&#8208;directed interventions could ameliorate pathological immune cell infiltration in fibrotic livers, particularly by modulating KC polarization and monocyte&#8208;derived macrophage dynamics. Future investigations should prioritize multiomics profiling of tissue&#8208;resident immune cells to identify conserved molecular checkpoints governing HSC&#8208;immune cross talk. Such mechanistic insights may pave the way for precision therapies combining senolytic agents with microenvironment&#8208;modulating biologics, ultimately fostering innovative therapeutic paradigms that address both cellular senescence and maladaptive immunity in CLDs.</p></sec><sec id="ame270053-sec-0022"><title>AUTHOR CONTRIBUTIONS</title><p>
<bold>Yue Wang:</bold> Conceptualization; validation; visualization; writing &#8211; original draft. <bold>Yiming Liu:</bold> Visualization; writing &#8211; review and editing. <bold>Dan Chen:</bold> Visualization; writing &#8211; review and editing. <bold>Leiming Liu:</bold> Supervision; visualization; writing &#8211; original draft; writing &#8211; review and editing. <bold>Leimin Sun:</bold> Supervision; validation; writing &#8211; review and editing. <bold>Lingling Zhang:</bold> Conceptualization; funding acquisition; visualization; writing &#8211; original draft; writing &#8211; review and editing.</p></sec><sec id="ame270053-sec-0019"><title>FUNDING INFORMATION</title><p>This work was supported by the National Natural Science Foundation of China (882171545, 91949125), as well as the National Key Research and Development Program of China (2021YFA0804903), the Start&#8208;up Fund for Distinguished Research Fellows at the International Institute of Health Medicine, Zhejiang University (Q22005).</p></sec><sec sec-type="COI-statement" id="ame270053-sec-0020"><title>CONFLICT OF INTEREST STATEMENT</title><p>Lingling Zhang is an editorial board member of Animal Models and Experimental Medicine (<italic toggle="yes">AMEM</italic>) and a corresponding author of this article. To minimize bias, she was excluded from all editorial decision making related to the acceptance of this article for publication.</p></sec><sec id="ame270053-sec-0021"><title>ETHICS STATEMENT</title><p>None.</p></sec></body><back><ack id="ame270053-sec-0018"><title>ACKNOWLEDGMENTS</title><p>The authors have nothing to report.</p></ack><ref-list content-type="cited-references" id="ame270053-bibl-0001"><title>REFERENCES</title><ref id="ame270053-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="ame270053-cit-0001"><string-name name-style="western"><surname>Tham</surname><given-names>EKJ</given-names></string-name>, <string-name name-style="western"><surname>Tan</surname><given-names>DJH</given-names></string-name>, <string-name name-style="western"><surname>Danpanichkul</surname><given-names>P</given-names></string-name>, et&#160;al. <article-title>The global burden of cirrhosis and other chronic liver diseases in 2021</article-title>. <source>Liver Int</source>. <year>2025</year>;<volume>45</volume>(<issue>3</issue>):<elocation-id>e70001</elocation-id>.<pub-id pub-id-type="pmid">39927433</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/liv.70001</pub-id><pub-id pub-id-type="pmcid">PMC11808647</pub-id></mixed-citation></ref><ref id="ame270053-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="ame270053-cit-0002"><string-name name-style="western"><surname>Younossi</surname><given-names>ZM</given-names></string-name>, <string-name name-style="western"><surname>Wong</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Anstee</surname><given-names>QM</given-names></string-name>, <string-name name-style="western"><surname>Henry</surname><given-names>L</given-names></string-name>. <article-title>The global burden of liver disease</article-title>. <source>Clin Gastroenterol Hepatol</source>. <year>2023</year>;<volume>21</volume>(<issue>8</issue>):<fpage>1978</fpage>&#8208;<lpage>1991</lpage>.<pub-id pub-id-type="pmid">37121527</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cgh.2023.04.015</pub-id></mixed-citation></ref><ref id="ame270053-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="ame270053-cit-0003"><string-name name-style="western"><surname>Mederacke</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Hsu</surname><given-names>CC</given-names></string-name>, <string-name name-style="western"><surname>Troeger</surname><given-names>JS</given-names></string-name>, et&#160;al. <article-title>Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology</article-title>. <source>Nat Commun</source>. <year>2013</year>;<volume>4</volume>:<fpage>2823</fpage>.<pub-id pub-id-type="pmid">24264436</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/ncomms3823</pub-id><pub-id pub-id-type="pmcid">PMC4059406</pub-id></mixed-citation></ref><ref id="ame270053-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="ame270053-cit-0004"><collab collab-type="authors">European Association for the Study of the Liver</collab>
. <article-title>EASL clinical practice guidelines on liver transplantation</article-title>. <source>J Hepatol</source>. <year>2024</year>;<volume>81</volume>(<issue>6</issue>):<fpage>1040</fpage>&#8208;<lpage>1086</lpage>.<pub-id pub-id-type="pmid">39487043</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jhep.2024.07.032</pub-id></mixed-citation></ref><ref id="ame270053-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="ame270053-cit-0005"><string-name name-style="western"><surname>Huang</surname><given-names>DQ</given-names></string-name>, <string-name name-style="western"><surname>Mathurin</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Cortez&#8208;Pinto</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Loomba</surname><given-names>R</given-names></string-name>. <article-title>Global epidemiology of alcohol&#8208;associated cirrhosis and HCC: trends, projections and risk factors</article-title>. <source>Nat Rev Gastroenterol Hepatol</source>. <year>2023</year>;<volume>20</volume>(<issue>1</issue>):<fpage>37</fpage>&#8208;<lpage>49</lpage>.<pub-id pub-id-type="pmid">36258033</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41575-022-00688-6</pub-id><pub-id pub-id-type="pmcid">PMC9579565</pub-id></mixed-citation></ref><ref id="ame270053-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="ame270053-cit-0006"><string-name name-style="western"><surname>Liu</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Jiang</surname><given-names>X</given-names></string-name>, et&#160;al. <article-title>LiverRisk score: an accurate, cost&#8208;effective tool to predict fibrosis, liver&#8208;related, and diabetes&#8208;related mortality in the general population</article-title>. <source>Fortschr Med</source>. <year>2024</year>;<volume>5</volume>(<issue>6</issue>):<fpage>570</fpage>&#8208;<lpage>582</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.medj.2024.03.003</pub-id><pub-id pub-id-type="pmid">38554711</pub-id></mixed-citation></ref><ref id="ame270053-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="ame270053-cit-0007"><collab collab-type="authors">GBD 2021 Demographics Collaborators</collab>
. <article-title>Global age&#8208;sex&#8208;specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950&#8208;2021, and the impact of the COVID&#8208;19 pandemic: a comprehensive demographic analysis for the global burden of disease study 2021</article-title>. <source>Lancet</source>. <year>2024</year>;<volume>403</volume>(<issue>10440</issue>):<fpage>1989</fpage>&#8208;<lpage>2056</lpage>.<pub-id pub-id-type="pmid">38484753</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S0140-6736(24)00476-8</pub-id><pub-id pub-id-type="pmcid">PMC11126395</pub-id></mixed-citation></ref><ref id="ame270053-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="ame270053-cit-0008"><string-name name-style="western"><surname>Han</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Ge</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Komakula</surname><given-names>SSB</given-names></string-name>, et&#160;al. <article-title>Macrophage&#8208;derived Osteopontin (SPP1) protects from nonalcoholic steatohepatitis</article-title>. <source>Gastroenterology</source>. <year>2023</year>;<volume>165</volume>(<issue>1</issue>):<fpage>201</fpage>&#8208;<lpage>217</lpage>.<pub-id pub-id-type="pmid">37028770</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1053/j.gastro.2023.03.228</pub-id><pub-id pub-id-type="pmcid">PMC10986640</pub-id></mixed-citation></ref><ref id="ame270053-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="ame270053-cit-0009"><string-name name-style="western"><surname>Guillot</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Winkler</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Silva Afonso</surname><given-names>M</given-names></string-name>, et&#160;al. <article-title>Mapping the hepatic immune landscape identifies monocytic macrophages as key drivers of steatohepatitis and cholangiopathy progression</article-title>. <source>Hepatology</source>. <year>2023</year>;<volume>78</volume>(<issue>1</issue>):<fpage>150</fpage>&#8208;<lpage>166</lpage>.<pub-id pub-id-type="pmid">36630995</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/HEP.0000000000000270</pub-id></mixed-citation></ref><ref id="ame270053-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="ame270053-cit-0010"><string-name name-style="western"><surname>Cui</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Wallace</surname><given-names>MS</given-names></string-name>, et&#160;al. <article-title>Single&#8208;cell atlas of the liver myeloid compartment before and after cure of chronic viral hepatitis</article-title>. <source>J Hepatol</source>. <year>2024</year>;<volume>80</volume>(<issue>2</issue>):<fpage>251</fpage>.<pub-id pub-id-type="pmid">36972796</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jhep.2023.02.040</pub-id><pub-id pub-id-type="pmcid">PMC11651724</pub-id></mixed-citation></ref><ref id="ame270053-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="ame270053-cit-0011"><string-name name-style="western"><surname>Peiseler</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Schwabe</surname><given-names>RF</given-names></string-name>, <string-name name-style="western"><surname>Hampe</surname><given-names>J</given-names></string-name>, et&#160;al. <article-title>Immune mechanisms linking metabolic injury to inflammation and fibrosis in fatty liver disease &#8208; novel insights into cellular communication circuits</article-title>. <source>J Hepatol</source>. <year>2022</year>;<volume>77</volume>(<issue>4</issue>):<fpage>1136</fpage>&#8208;<lpage>1160</lpage>.<pub-id pub-id-type="pmid">35750137</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jhep.2022.06.012</pub-id></mixed-citation></ref><ref id="ame270053-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="ame270053-cit-0012"><string-name name-style="western"><surname>Wei</surname><given-names>Q</given-names></string-name>, <string-name name-style="western"><surname>Frenette</surname><given-names>PS</given-names></string-name>. <article-title>Niches for hematopoietic stem cells and their progeny</article-title>. <source>Immunity</source>. <year>2018</year>;<volume>48</volume>(<issue>4</issue>):<fpage>632</fpage>&#8208;<lpage>648</lpage>.<pub-id pub-id-type="pmid">29669248</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.immuni.2018.03.024</pub-id><pub-id pub-id-type="pmcid">PMC6103525</pub-id></mixed-citation></ref><ref id="ame270053-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="ame270053-cit-0013"><string-name name-style="western"><surname>Morrison</surname><given-names>SJ</given-names></string-name>, <string-name name-style="western"><surname>Scadden</surname><given-names>DT</given-names></string-name>. <article-title>The bone marrow niche for haematopoietic stem cells</article-title>. <source>Nature</source>. <year>2014</year>;<volume>505</volume>(<issue>7483</issue>):<fpage>327</fpage>&#8208;<lpage>334</lpage>.<pub-id pub-id-type="pmid">24429631</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nature12984</pub-id><pub-id pub-id-type="pmcid">PMC4514480</pub-id></mixed-citation></ref><ref id="ame270053-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="ame270053-cit-0014"><string-name name-style="western"><surname>Hou</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>K&#8208;X</given-names></string-name>, <string-name name-style="western"><surname>He</surname><given-names>C</given-names></string-name>, et&#160;al. <article-title>Aged bone marrow macrophages drive systemic aging and age&#8208;related dysfunction via extracellular vesicle&#8208;mediated induction of paracrine senescence</article-title>. <source>Nat Aging</source>. <year>2024</year>;<volume>4</volume>(<issue>11</issue>):<fpage>1562</fpage>.<pub-id pub-id-type="pmid">39266768</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s43587-024-00694-0</pub-id><pub-id pub-id-type="pmcid">PMC11564114</pub-id></mixed-citation></ref><ref id="ame270053-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="ame270053-cit-0015"><string-name name-style="western"><surname>Li</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Ren</surname><given-names>Y</given-names></string-name>, et&#160;al. <article-title>Aging and age&#8208;related diseases: from mechanisms to therapeutic strategies</article-title>. <source>Biogerontology</source>. <year>2021</year>;<volume>22</volume>(<issue>2</issue>):<fpage>165</fpage>&#8208;<lpage>187</lpage>.<pub-id pub-id-type="pmid">33502634</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s10522-021-09910-5</pub-id><pub-id pub-id-type="pmcid">PMC7838467</pub-id></mixed-citation></ref><ref id="ame270053-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="ame270053-cit-0016"><string-name name-style="western"><surname>Liberale</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Badimon</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Montecucco</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>L&#252;scher</surname><given-names>TF</given-names></string-name>, <string-name name-style="western"><surname>Libby</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Camici</surname><given-names>GG</given-names></string-name>. <article-title>Inflammation, aging, and cardiovascular disease JACC review topic of the week</article-title>. <source>J Am Coll Cardiol</source>. <year>2022</year>;<volume>79</volume>(<issue>8</issue>):<fpage>837</fpage>&#8208;<lpage>847</lpage>.<pub-id pub-id-type="pmid">35210039</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jacc.2021.12.017</pub-id><pub-id pub-id-type="pmcid">PMC8881676</pub-id></mixed-citation></ref><ref id="ame270053-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="ame270053-cit-0017"><string-name name-style="western"><surname>Fekete</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Major</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Feher</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Fazekas&#8208;Pongor</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Lehoczki</surname><given-names>A</given-names></string-name>. <article-title>Geroscience and pathology: a new frontier in understanding age&#8208;related diseases</article-title>. <source>Pathol Oncol</source>. <year>2024</year>;<volume>30</volume>:<elocation-id>1611623</elocation-id>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/pore.2024.1611623</pub-id><pub-id pub-id-type="pmcid">PMC10922957</pub-id><pub-id pub-id-type="pmid">38463143</pub-id></mixed-citation></ref><ref id="ame270053-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="ame270053-cit-0018"><string-name name-style="western"><surname>Singh</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Chia</surname><given-names>JJ</given-names></string-name>, <string-name name-style="western"><surname>Rao</surname><given-names>DS</given-names></string-name>, <string-name name-style="western"><surname>Hoffmann</surname><given-names>A</given-names></string-name>. <article-title>Population dynamics modeling reveals that myeloid bias involves both HSC differentiation and progenitor proliferation biases</article-title>. <source>Blood</source>. <year>2025</year>;<volume>145</volume>(<issue>12</issue>):<fpage>1293</fpage>&#8208;<lpage>1308</lpage>.<pub-id pub-id-type="pmid">39791596</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1182/blood.2024025598</pub-id><pub-id pub-id-type="pmcid">PMC11952015</pub-id></mixed-citation></ref><ref id="ame270053-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="ame270053-cit-0019"><string-name name-style="western"><surname>Farhat</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Radhouani</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Deckert</surname><given-names>F</given-names></string-name>, et&#160;al. <article-title>An aging bone marrow exacerbates lung fibrosis by fueling profibrotic macrophage persistence</article-title>. <source>Sci Immunol</source>. <year>2025</year>;<volume>10</volume>(<issue>105</issue>):<elocation-id>eadk5041</elocation-id>.<pub-id pub-id-type="pmid">40153488</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/sciimmunol.adk5041</pub-id></mixed-citation></ref><ref id="ame270053-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="ame270053-cit-0020"><string-name name-style="western"><surname>Wang</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Divaris</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Pan</surname><given-names>B</given-names></string-name>, et&#160;al. <article-title>Clonal hematopoiesis driven by mutated DNMT3A bone loss</article-title>. <source>Cell</source>. <year>2024</year>;<volume>187</volume>(<issue>14</issue>):<fpage>3690</fpage>&#8211;<lpage>3711</lpage>.<pub-id pub-id-type="pmid">38838669</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cell.2024.05.003</pub-id><pub-id pub-id-type="pmcid">PMC11246233</pub-id></mixed-citation></ref><ref id="ame270053-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="ame270053-cit-0021"><string-name name-style="western"><surname>Vlasschaert</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Robinson&#8208;Cohen</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>J</given-names></string-name>, et&#160;al. <article-title>Clonal hematopoiesis of indeterminate potential is associated with acute kidney injury</article-title>. <source>Nat Med</source>. <year>2024</year>;<volume>30</volume>(<issue>3</issue>):<fpage>810</fpage>.<pub-id pub-id-type="pmid">38454125</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41591-024-02854-6</pub-id><pub-id pub-id-type="pmcid">PMC10957477</pub-id></mixed-citation></ref><ref id="ame270053-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="ame270053-cit-0022"><string-name name-style="western"><surname>Abplanalp</surname><given-names>WT</given-names></string-name>, <string-name name-style="western"><surname>Cremer</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>John</surname><given-names>D</given-names></string-name>, et&#160;al. <article-title>Clonal hematopoiesis&#8208;driver DNMT3A mutations Alter immune cells in heart failure</article-title>. <source>Circ Res</source>. <year>2021</year>;<volume>128</volume>(<issue>2</issue>):<fpage>216</fpage>&#8208;<lpage>228</lpage>.<pub-id pub-id-type="pmid">33155517</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/CIRCRESAHA.120.317104</pub-id></mixed-citation></ref><ref id="ame270053-bib-0023"><label>23</label><mixed-citation publication-type="journal" id="ame270053-cit-0023"><string-name name-style="western"><surname>Park</surname><given-names>MD</given-names></string-name>, <string-name name-style="western"><surname>Le Berichel</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Hamon</surname><given-names>P</given-names></string-name>, et&#160;al. <article-title>Hematopoietic aging promotes cancer by fueling IL&#8208;1&#945;&#8208;driven emergency myelopoiesis</article-title>. <source>Science</source>. <year>2024</year>;<volume>386</volume>(<issue>6720</issue>):<elocation-id>eadn0327</elocation-id>. doi:<pub-id pub-id-type="doi">10.1126/science.adn0327</pub-id><pub-id pub-id-type="pmid">39236155</pub-id><pub-id pub-id-type="pmcid">PMC7616710</pub-id></mixed-citation></ref><ref id="ame270053-bib-0024"><label>24</label><mixed-citation publication-type="journal" id="ame270053-cit-0024"><string-name name-style="western"><surname>Leavens</surname><given-names>KF</given-names></string-name>, <string-name name-style="western"><surname>Alvarez&#8208;Dominguez</surname><given-names>JR</given-names></string-name>, <string-name name-style="western"><surname>Vo</surname><given-names>LT</given-names></string-name>, et&#160;al. <article-title>Stem cell&#8208;based multi&#8208;tissue platforms to model human autoimmune diabetes</article-title>. <source>Mol Metab</source>. <year>2022</year>;<volume>66</volume>:<elocation-id>101610</elocation-id>. doi:<pub-id pub-id-type="doi">10.1016/j.molmet.2022.101610</pub-id><pub-id pub-id-type="pmid">36209784</pub-id><pub-id pub-id-type="pmcid">PMC9587366</pub-id></mixed-citation></ref><ref id="ame270053-bib-0025"><label>25</label><mixed-citation publication-type="journal" id="ame270053-cit-0025"><string-name name-style="western"><surname>Wu</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Parks&#8208;Schenck</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Guo</surname><given-names>T</given-names></string-name>, et&#160;al. <article-title>Heterogeneity of single cells obtained from peripheral blood mononuclear cells collected from youth with recent&#8208;onset type 1 diabetes</article-title>. <source>Diabetes</source>. <year>2023</year>;<volume>72</volume>:<fpage>217&#8208;LB</fpage>.</mixed-citation></ref><ref id="ame270053-bib-0026"><label>26</label><mixed-citation publication-type="journal" id="ame270053-cit-0026"><string-name name-style="western"><surname>Wong</surname><given-names>WJ</given-names></string-name>, <string-name name-style="western"><surname>Emdin</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Bick</surname><given-names>AG</given-names></string-name>, et&#160;al. <article-title>Clonal haematopoiesis and risk of chronic liver disease</article-title>. <source>Nature</source>. <year>2023</year>;<volume>616</volume>(<issue>7958</issue>):<fpage>747</fpage>&#8211;<lpage>754</lpage>.<pub-id pub-id-type="pmid">37046084</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41586-023-05857-4</pub-id><pub-id pub-id-type="pmcid">PMC10405350</pub-id></mixed-citation></ref><ref id="ame270053-bib-0027"><label>27</label><mixed-citation publication-type="journal" id="ame270053-cit-0027"><string-name name-style="western"><surname>Yoon</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Jeong</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Park</surname><given-names>J&#8208;H</given-names></string-name>. <article-title>Intratumoral adoptive transfer of inflammatory macrophages engineered by co&#8208;activating TLR and STING signaling pathways exhibits robust antitumor activity</article-title>. <source>Clin Exp Med</source>. <year>2023</year>;<volume>23</volume>(<issue>8</issue>):<fpage>5025</fpage>&#8208;<lpage>5037</lpage>.<pub-id pub-id-type="pmid">37535193</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s10238-023-01157-3</pub-id></mixed-citation></ref><ref id="ame270053-bib-0028"><label>28</label><mixed-citation publication-type="journal" id="ame270053-cit-0028"><string-name name-style="western"><surname>Ouyang</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Nauwynck</surname><given-names>HJ</given-names></string-name>. <article-title>PCV2 uptake by porcine monocytes is strain&#8208;dependent and is associated with amino acid characteristics on the capsid surface</article-title>. <source>Microbiol Spectr</source>. <year>2023</year>;<volume>11</volume>(<issue>2</issue>):<elocation-id>e0380522</elocation-id>. doi:<pub-id pub-id-type="doi">10.1128/spectrum.03805-22</pub-id><pub-id pub-id-type="pmid">36719220</pub-id><pub-id pub-id-type="pmcid">PMC10100887</pub-id></mixed-citation></ref><ref id="ame270053-bib-0029"><label>29</label><mixed-citation publication-type="journal" id="ame270053-cit-0029"><string-name name-style="western"><surname>Li</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Ren</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Chang</surname><given-names>K</given-names></string-name>, et&#160;al. <article-title>Adipose tissue macrophages as potential targets for obesity and metabolic diseases</article-title>. <source>Front Immunol</source>. <year>2023</year>;<volume>14</volume>:<elocation-id>1153915</elocation-id>. doi:<pub-id pub-id-type="doi">10.3389/fimmu.2023.1153915</pub-id><pub-id pub-id-type="pmid">37153549</pub-id><pub-id pub-id-type="pmcid">PMC10154623</pub-id></mixed-citation></ref><ref id="ame270053-bib-0030"><label>30</label><mixed-citation publication-type="journal" id="ame270053-cit-0030"><string-name name-style="western"><surname>Kwon</surname><given-names>Y&#8208;W</given-names></string-name>, <string-name name-style="western"><surname>Chae</surname><given-names>C&#8208;W</given-names></string-name>, <string-name name-style="western"><surname>Lee</surname><given-names>H</given-names></string-name>, et&#160;al. <article-title>A subset of macrophages and monocytes in the mouse bone marrow express atypical chemokine receptor 1</article-title>. <source>Cell Stem Cell</source>. <year>2022</year>;<volume>29</volume>(<issue>7</issue>):<fpage>1016</fpage>&#8211;<lpage>1017</lpage>.<pub-id pub-id-type="pmid">35803223</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.stem.2022.06.011</pub-id></mixed-citation></ref><ref id="ame270053-bib-0031"><label>31</label><mixed-citation publication-type="journal" id="ame270053-cit-0031"><string-name name-style="western"><surname>Szukiewicz</surname><given-names>D</given-names></string-name>. <article-title>CX3CL1 (fractalkine)&#8208;CX3CR1 Axis in inflammation&#8208;induced angiogenesis and tumorigenesis</article-title>. <source>Int J Mol Sci</source>. <year>2024</year>;<volume>25</volume>(<issue>9</issue>):<elocation-id>4679</elocation-id>. doi:<pub-id pub-id-type="doi">10.3390/ijms25094679</pub-id><pub-id pub-id-type="pmid">38731899</pub-id><pub-id pub-id-type="pmcid">PMC11083509</pub-id></mixed-citation></ref><ref id="ame270053-bib-0032"><label>32</label><mixed-citation publication-type="journal" id="ame270053-cit-0032"><string-name name-style="western"><surname>Rivas&#8208;Fuentes</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Salgado&#8208;Aguayo</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Santos&#8208;Mendoza</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Sevilla&#8208;Reyes</surname><given-names>E</given-names></string-name>. <article-title>The role of the CX3CR1&#8208;CX3CL1 Axis in respiratory syncytial virus infection and the triggered immune response</article-title>. <source>Int J Mol Sci</source>. <year>2024</year>;<volume>25</volume>(<issue>18</issue>):<elocation-id>9800</elocation-id>. doi:<pub-id pub-id-type="doi">10.3390/ijms25189800</pub-id><pub-id pub-id-type="pmid">39337288</pub-id><pub-id pub-id-type="pmcid">PMC11432029</pub-id></mixed-citation></ref><ref id="ame270053-bib-0033"><label>33</label><mixed-citation publication-type="journal" id="ame270053-cit-0033"><string-name name-style="western"><surname>Herrero&#8208;Cervera</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Soehnlein</surname><given-names>O</given-names></string-name>, <string-name name-style="western"><surname>Kenne</surname><given-names>E</given-names></string-name>. <article-title>Neutrophils in chronic inflammatory diseases</article-title>. <source>Cell Mol Immunol</source>. <year>2022</year>;<volume>19</volume>(<issue>2</issue>):<fpage>177</fpage>&#8208;<lpage>191</lpage>.<pub-id pub-id-type="pmid">35039631</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41423-021-00832-3</pub-id><pub-id pub-id-type="pmcid">PMC8803838</pub-id></mixed-citation></ref><ref id="ame270053-bib-0034"><label>34</label><mixed-citation publication-type="journal" id="ame270053-cit-0034"><string-name name-style="western"><surname>Dahl</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Walsh</surname><given-names>JC</given-names></string-name>, <string-name name-style="western"><surname>Lancki</surname><given-names>D</given-names></string-name>, et&#160;al. <article-title>Regulation of macrophage and neutrophil cell fates by the PU.1:C/EBP ratio and granulocyte colony&#8208;stimulating factor</article-title>. <source>Nat Immunol</source>. <year>2003</year>;<volume>4</volume>(<issue>10</issue>):<fpage>1029</fpage>&#8208;<lpage>1036</lpage>.<pub-id pub-id-type="pmid">12958595</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/ni973</pub-id></mixed-citation></ref><ref id="ame270053-bib-0035"><label>35</label><mixed-citation publication-type="journal" id="ame270053-cit-0035"><string-name name-style="western"><surname>Liu</surname><given-names>Q</given-names></string-name>, <string-name name-style="western"><surname>Yu</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>L</given-names></string-name>, et&#160;al. <article-title>Inhibition of PU.1 ameliorates metabolic dysfunction and non&#8208;alcoholic steatohepatitis</article-title>. <source>J Hepatol</source>. <year>2020</year>;<volume>73</volume>(<issue>2</issue>):<fpage>361</fpage>&#8208;<lpage>370</lpage>.<pub-id pub-id-type="pmid">32135178</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jhep.2020.02.025</pub-id></mixed-citation></ref><ref id="ame270053-bib-0036"><label>36</label><mixed-citation publication-type="journal" id="ame270053-cit-0036"><string-name name-style="western"><surname>Liu</surname><given-names>M&#8208;K</given-names></string-name>, <string-name name-style="western"><surname>Tang</surname><given-names>J&#8208;J</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>H</given-names></string-name>, et&#160;al. <article-title>Artemisitene ameliorates carbon tetrachloride&#8208;induced liver fibrosis by inhibiting NLRP3 inflammasome activation and modulating immune responses</article-title>. <source>Int Immunopharmacol</source>. <year>2025</year>;<volume>146</volume>:<elocation-id>113818</elocation-id>.<pub-id pub-id-type="pmid">39681062</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.intimp.2024.113818</pub-id></mixed-citation></ref><ref id="ame270053-bib-0037"><label>37</label><mixed-citation publication-type="journal" id="ame270053-cit-0037"><string-name name-style="western"><surname>Chu</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Yang</surname><given-names>C</given-names></string-name>, et&#160;al. <article-title>Neutrophil extracellular traps drive intestinal microvascular endothelial ferroptosis by impairing Fundc1&#8208;dependent mitophagy</article-title>. <source>Redox Biol</source>. <year>2023</year>;<volume>67</volume>:<elocation-id>102906</elocation-id>. doi:<pub-id pub-id-type="doi">10.1016/j.redox.2023.102906</pub-id><pub-id pub-id-type="pmid">37812880</pub-id><pub-id pub-id-type="pmcid">PMC10579540</pub-id></mixed-citation></ref><ref id="ame270053-bib-0038"><label>38</label><mixed-citation publication-type="journal" id="ame270053-cit-0038"><string-name name-style="western"><surname>Bhattacharyya</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Oon</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Diaz</surname><given-names>L</given-names></string-name>, et&#160;al. <article-title>Autotaxin&#8208;lysolipid signaling suppresses a CCL11&#8208;eosinophil axis to promote pancreatic cancer progression</article-title>. <source>Nat Can</source>. <year>2024</year>;<volume>5</volume>(<issue>2</issue>):<fpage>283</fpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s43018-023-00703-y</pub-id><pub-id pub-id-type="pmcid">PMC10899115</pub-id><pub-id pub-id-type="pmid">38195933</pub-id></mixed-citation></ref><ref id="ame270053-bib-0039"><label>39</label><mixed-citation publication-type="journal" id="ame270053-cit-0039"><string-name name-style="western"><surname>Reissing</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Berres</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Strnad</surname><given-names>P</given-names></string-name>, et&#160;al. <article-title>Th2 cell activation in chronic liver disease is driven by local IL33 and contributes to IL13&#8208;dependent fibrogenesis</article-title>. <source>Cell Mol Gastroenterol Hepatol</source>. <year>2024</year>;<volume>17</volume>(<issue>4</issue>):<fpage>517</fpage>&#8208;<lpage>538</lpage>.<pub-id pub-id-type="pmid">38158122</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jcmgh.2023.12.011</pub-id><pub-id pub-id-type="pmcid">PMC10882164</pub-id></mixed-citation></ref><ref id="ame270053-bib-0040"><label>40</label><mixed-citation publication-type="journal" id="ame270053-cit-0040"><string-name name-style="western"><surname>Cristina Negrete&#8208;Garcia</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Velazquez</surname><given-names>JR</given-names></string-name>, <string-name name-style="western"><surname>Popoca&#8208;Coyotl</surname><given-names>A</given-names></string-name>, et&#160;al. <article-title>Chemokine (C&#8208;X&#8208;C motif) ligand 12/stromal cell&#8208;derived Factor&#8208;1 is associated with leukocyte recruitment in asthma</article-title>. <source>Chest</source>. <year>2010</year>;<volume>138</volume>(<issue>1</issue>):<fpage>100</fpage>&#8208;<lpage>106</lpage>.<pub-id pub-id-type="pmid">20299631</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1378/chest.09-2104</pub-id></mixed-citation></ref><ref id="ame270053-bib-0041"><label>41</label><mixed-citation publication-type="journal" id="ame270053-cit-0041"><string-name name-style="western"><surname>Zhang</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Zhao</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Dai</surname><given-names>W</given-names></string-name>, et&#160;al. <article-title>Disruption of cholangiocyte&#8208;B cell crosstalk by blocking the CXCL12&#8208;CXCR4 axis alleviates liver fibrosis</article-title>. <source>Cell Mol Life Sci</source>. <year>2023</year>;<volume>80</volume>(<issue>12</issue>):<fpage>379</fpage>.<pub-id pub-id-type="pmid">38010435</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00018-023-05032-y</pub-id><pub-id pub-id-type="pmcid">PMC11072584</pub-id></mixed-citation></ref><ref id="ame270053-bib-0042"><label>42</label><mixed-citation publication-type="journal" id="ame270053-cit-0042"><string-name name-style="western"><surname>Aguilar&#8208;Bravo</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Arino</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Blaya</surname><given-names>D</given-names></string-name>, et&#160;al. <article-title>Hepatocyte dedifferentiation profiling in alcohol&#8208;related liver disease identifies CXCR4 As A driver of cell reprogramming</article-title>. <source>J Hepatol.</source><year>2023</year>;<volume>79</volume>(<issue>3</issue>):<fpage>728</fpage>&#8211;<lpage>740</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jhep.2023.04.013</pub-id><pub-id pub-id-type="pmid">37088308</pub-id><pub-id pub-id-type="pmcid">PMC10540088</pub-id></mixed-citation></ref><ref id="ame270053-bib-0043"><label>43</label><mixed-citation publication-type="journal" id="ame270053-cit-0043"><string-name name-style="western"><surname>Bernard</surname><given-names>JK</given-names></string-name>, <string-name name-style="western"><surname>Marakovits</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Smith</surname><given-names>LG</given-names></string-name>, <string-name name-style="western"><surname>Francis</surname><given-names>H</given-names></string-name>. <article-title>Mast cell and innate immune cell communication in cholestatic liver disease</article-title>. <source>Semin Liver Dis</source>. <year>2023</year>;<volume>43</volume>(<issue>2</issue>):<fpage>226</fpage>&#8208;<lpage>233</lpage>.<pub-id pub-id-type="pmid">37268012</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1055/a-2104-9034</pub-id></mixed-citation></ref><ref id="ame270053-bib-0044"><label>44</label><mixed-citation publication-type="journal" id="ame270053-cit-0044"><string-name name-style="western"><surname>Chen</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Feng</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Sun</surname><given-names>M</given-names></string-name>, et&#160;al. <article-title>TGF&#8208;b1&#8208;induced SOX18 elevation promotes hepatocellular carcinoma progression and metastasis through transcriptionally upregulating PD&#8208;L1 and CXCL12</article-title>. <source>Gastroenterology</source>. <year>2024</year>;<volume>167</volume>(<issue>2</issue>):<fpage>264</fpage>&#8208;<lpage>280</lpage>.<pub-id pub-id-type="pmid">38417530</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1053/j.gastro.2024.02.025</pub-id></mixed-citation></ref><ref id="ame270053-bib-0045"><label>45</label><mixed-citation publication-type="journal" id="ame270053-cit-0045"><string-name name-style="western"><surname>Zhang</surname><given-names>J&#8208;M</given-names></string-name>, <string-name name-style="western"><surname>Huang</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>X&#8208;Q</given-names></string-name>, et&#160;al. <article-title>FLT3+DC inhibits immune rejection via interaction with Treg in liver transplantation</article-title>. <source>Int Immunopharmacol</source>. <year>2024</year>;<volume>137</volume>:<elocation-id>112289</elocation-id>.<pub-id pub-id-type="pmid">38889505</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.intimp.2024.112289</pub-id></mixed-citation></ref><ref id="ame270053-bib-0046"><label>46</label><mixed-citation publication-type="journal" id="ame270053-cit-0046"><string-name name-style="western"><surname>van Montfoort</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>van der Aa</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>van den Bosch</surname><given-names>A</given-names></string-name>, et&#160;al. <article-title>Hepatitis B virus surface antigen activates myeloid dendritic cells via a soluble CD14&#8208;dependent mechanism</article-title>. <source>J Virol</source>. <year>2016</year>;<volume>90</volume>(<issue>14</issue>):<fpage>6187</fpage>&#8208;<lpage>6199</lpage>.<pub-id pub-id-type="pmid">27099316</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/JVI.02903-15</pub-id><pub-id pub-id-type="pmcid">PMC4936135</pub-id></mixed-citation></ref><ref id="ame270053-bib-0047"><label>47</label><mixed-citation publication-type="journal" id="ame270053-cit-0047"><string-name name-style="western"><surname>Cheng</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Chai</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Fu</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Peng</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Ni</surname><given-names>X</given-names></string-name>. <article-title>Hepatic macrophages: key players in the development and progression of liver fibrosis</article-title>. <source>Liver Int</source>. <year>2021</year>;<volume>41</volume>(<issue>10</issue>):<fpage>2279</fpage>&#8208;<lpage>2294</lpage>.<pub-id pub-id-type="pmid">33966318</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/liv.14940</pub-id></mixed-citation></ref><ref id="ame270053-bib-0048"><label>48</label><mixed-citation publication-type="journal" id="ame270053-cit-0048"><string-name name-style="western"><surname>Varol</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Mildner</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Jung</surname><given-names>S</given-names></string-name>. <article-title>Macrophages: development and tissue specialization</article-title>. <source>Annu Rev Immunol</source>. <year>2015</year>;<volume>33</volume>:<fpage>643</fpage>&#8208;<lpage>675</lpage>.<pub-id pub-id-type="pmid">25861979</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1146/annurev-immunol-032414-112220</pub-id></mixed-citation></ref><ref id="ame270053-bib-0049"><label>49</label><mixed-citation publication-type="journal" id="ame270053-cit-0049"><string-name name-style="western"><surname>David</surname><given-names>BA</given-names></string-name>, <string-name name-style="western"><surname>Rezende</surname><given-names>RM</given-names></string-name>, <string-name name-style="western"><surname>Antunes</surname><given-names>MM</given-names></string-name>, et&#160;al. <article-title>Combination of mass cytometry and imaging analysis reveals origin, location, and functional repopulation of liver myeloid cells in mice</article-title>. <source>Gastroenterology</source>. <year>2016</year>;<volume>151</volume>(<issue>6</issue>):<fpage>1176</fpage>&#8208;<lpage>1191</lpage>.<pub-id pub-id-type="pmid">27569723</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1053/j.gastro.2016.08.024</pub-id></mixed-citation></ref><ref id="ame270053-bib-0050"><label>50</label><mixed-citation publication-type="journal" id="ame270053-cit-0050"><string-name name-style="western"><surname>Song</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>N</given-names></string-name>. <article-title>MicroRNA&#8208;206 drives antitumor immunity by disrupting the communication between Kupffer cells and Tregs</article-title>. <source>Cancer Res</source>. <year>2023</year>;<volume>83</volume>(<issue>7</issue>). doi:<pub-id pub-id-type="doi">10.1158/1538-7445.AM2023-3808</pub-id></mixed-citation></ref><ref id="ame270053-bib-0051"><label>51</label><mixed-citation publication-type="journal" id="ame270053-cit-0051"><string-name name-style="western"><surname>Venzin</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Beccaria</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Fumagalli</surname><given-names>V</given-names></string-name>, et&#160;al. <article-title>CD4+T cells license Kupffer cells to revert the CD8+T cell dysfunction induced by hepatocellular priming</article-title>. <source>Eur J Immunol</source>. <year>2024</year>;<volume>54</volume>:<fpage>524</fpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41590-025-02199-3</pub-id><pub-id pub-id-type="pmcid">PMC12307227</pub-id><pub-id pub-id-type="pmid">40588520</pub-id></mixed-citation></ref><ref id="ame270053-bib-0052"><label>52</label><mixed-citation publication-type="journal" id="ame270053-cit-0052"><string-name name-style="western"><surname>Yu</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Xie</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Fan</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Jia</surname><given-names>J</given-names></string-name>. <article-title>Interferon &#945;2b increases MMP&#8208;13 and IL&#8208;10 expression in Kupffer cells through MAPK signaling pathways</article-title>. <source>Hepato&#8208;Gastroenterology</source>. <year>2015</year>;<volume>62</volume>(<issue>138</issue>):<fpage>350</fpage>&#8208;<lpage>354</lpage>.<pub-id pub-id-type="pmid">25993756</pub-id></mixed-citation></ref><ref id="ame270053-bib-0053"><label>53</label><mixed-citation publication-type="journal" id="ame270053-cit-0053"><string-name name-style="western"><surname>Liu</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Yu</surname><given-names>Q</given-names></string-name>, <string-name name-style="western"><surname>Wu</surname><given-names>W</given-names></string-name>, et&#160;al. <article-title>TLR2 stimulation strengthens intrahepatic myeloid&#8208;derived cell&#8208;mediated T cell tolerance through inducing Kupffer cell expansion and IL&#8208;10 production</article-title>. <source>J Immunol</source>. <year>2018</year>;<volume>200</volume>(<issue>7</issue>):<fpage>2341</fpage>&#8208;<lpage>2351</lpage>.<pub-id pub-id-type="pmid">29459406</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.4049/jimmunol.1700540</pub-id></mixed-citation></ref><ref id="ame270053-bib-0054"><label>54</label><mixed-citation publication-type="journal" id="ame270053-cit-0054"><string-name name-style="western"><surname>Karakas</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Ni</surname><given-names>H</given-names></string-name>. <article-title>Novel mechanisms of thrombopoietin generation: the essential role of Kupffer cells</article-title>. <source>Blood</source>. <year>2021</year>;<volume>138</volume>:<fpage>3139</fpage>.</mixed-citation></ref><ref id="ame270053-bib-0055"><label>55</label><mixed-citation publication-type="journal" id="ame270053-cit-0055"><string-name name-style="western"><surname>Jiang</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Tang</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Hoover</surname><given-names>C</given-names></string-name>, et&#160;al. <article-title>Kupffer cell receptor CLEC4F is important for the destruction of desialylated platelets in mice</article-title>. <source>Cell Death Differ</source>. <year>2021</year>;<volume>28</volume>(<issue>11</issue>):<fpage>3009</fpage>&#8208;<lpage>3021</lpage>.<pub-id pub-id-type="pmid">33993195</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41418-021-00797-w</pub-id><pub-id pub-id-type="pmcid">PMC8564511</pub-id></mixed-citation></ref><ref id="ame270053-bib-0056"><label>56</label><mixed-citation publication-type="journal" id="ame270053-cit-0056"><string-name name-style="western"><surname>Li</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Yang</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Yang</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Chang</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>L</given-names></string-name>. <article-title>Monocyte&#8208;derived Kupffer cells dominate in the Kupffer cell pool during liver injury</article-title>. <source>Cell Rep</source>. <year>2023</year>;<volume>42</volume>(<issue>10</issue>):<elocation-id>113164</elocation-id>.<pub-id pub-id-type="pmid">37740916</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.celrep.2023.113164</pub-id></mixed-citation></ref><ref id="ame270053-bib-0057"><label>57</label><mixed-citation publication-type="journal" id="ame270053-cit-0057"><string-name name-style="western"><surname>Peiseler</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>David</surname><given-names>BA</given-names></string-name>, <string-name name-style="western"><surname>Zindel</surname><given-names>J</given-names></string-name>, et&#160;al. <article-title>Kupffer cell&#8208;like syncytia replenish resident macrophage function in the fibrotic liver</article-title>. <source>Science</source>. <year>2023</year>;<volume>381</volume>(<issue>6662</issue>):<fpage>1066</fpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/science.abq5202</pub-id><pub-id pub-id-type="pmid">37676943</pub-id></mixed-citation></ref><ref id="ame270053-bib-0058"><label>58</label><mixed-citation publication-type="journal" id="ame270053-cit-0058"><string-name name-style="western"><surname>Wan</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Xu</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Yu</surname><given-names>C</given-names></string-name>, et&#160;al. <article-title>Role of NLRP3 inflammasome in the progression of NAFLD to NASH</article-title>. <source>Can J Gastroenterol Hepatol</source>. <year>2016</year>;<volume>2016</volume>:<elocation-id>6489012</elocation-id>.<pub-id pub-id-type="pmid">27446858</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1155/2016/6489012</pub-id><pub-id pub-id-type="pmcid">PMC4904645</pub-id></mixed-citation></ref><ref id="ame270053-bib-0059"><label>59</label><mixed-citation publication-type="journal" id="ame270053-cit-0059"><string-name name-style="western"><surname>Wu</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Dong</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Lin</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>J</given-names></string-name>. <article-title>Relevance of the NLRP3 inflammasome in the pathogenesis of chronic liver disease</article-title>. <source>Front Immunol</source>. <year>2017</year>;<volume>8</volume>:<fpage>1728</fpage>.<pub-id pub-id-type="pmid">29312290</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fimmu.2017.01728</pub-id><pub-id pub-id-type="pmcid">PMC5732938</pub-id></mixed-citation></ref><ref id="ame270053-bib-0060"><label>60</label><mixed-citation publication-type="journal" id="ame270053-cit-0060"><string-name name-style="western"><surname>Shapouri&#8208;Moghaddam</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Mohammadian</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Vazini</surname><given-names>H</given-names></string-name>, et&#160;al. <article-title>Macrophage plasticity, polarization, and function in health and disease</article-title>. <source>J Cell Physiol</source>. <year>2018</year>;<volume>233</volume>(<issue>9</issue>):<fpage>6425</fpage>&#8208;<lpage>6440</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/jcp.26429</pub-id><pub-id pub-id-type="pmid">29319160</pub-id></mixed-citation></ref><ref id="ame270053-bib-0061"><label>61</label><mixed-citation publication-type="journal" id="ame270053-cit-0061"><string-name name-style="western"><surname>Roh</surname><given-names>Y&#8208;S</given-names></string-name>, <string-name name-style="western"><surname>Seki</surname><given-names>E</given-names></string-name>. <article-title>Chemokines and chemokine receptors in the development of NAFLD</article-title>. <source>Adv Exp Med Biol</source>. <year>2018</year>;<volume>1061</volume>:<fpage>45</fpage>&#8208;<lpage>53</lpage>.<pub-id pub-id-type="pmid">29956205</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/978-981-10-8684-7_4</pub-id></mixed-citation></ref><ref id="ame270053-bib-0062"><label>62</label><mixed-citation publication-type="journal" id="ame270053-cit-0062"><string-name name-style="western"><surname>Ni</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Fen</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Ni</surname><given-names>L</given-names></string-name>, et&#160;al. <article-title>CX3CL1/CX3CR1 interaction protects against lipotoxicity&#8208;induced nonalcoholic steatohepatitis by regulating macrophage migration and M1/M2 status</article-title>. <source>Metabolism</source>. <year>2022</year>;<volume>136</volume>:<elocation-id>155272</elocation-id>. doi:<pub-id pub-id-type="doi">10.1016/j.metabol.2022.155272</pub-id><pub-id pub-id-type="pmid">35914622</pub-id></mixed-citation></ref><ref id="ame270053-bib-0063"><label>63</label><mixed-citation publication-type="journal" id="ame270053-cit-0063"><string-name name-style="western"><surname>Dal&#8208;Secco</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Zeng</surname><given-names>Z</given-names></string-name>, et&#160;al. <article-title>A dynamic spectrum of monocytes arising from the in&#160;situ reprogramming of CCR2<sup>+</sup> monocytes at a site of sterile injury</article-title>. <source>J Exp Med</source>. <year>2015</year>;<volume>212</volume>(<issue>4</issue>):<fpage>447</fpage>&#8208;<lpage>456</lpage>.<pub-id pub-id-type="pmid">25800956</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1084/jem.20141539</pub-id><pub-id pub-id-type="pmcid">PMC4387291</pub-id></mixed-citation></ref><ref id="ame270053-bib-0064"><label>64</label><mixed-citation publication-type="journal" id="ame270053-cit-0064"><string-name name-style="western"><surname>Martin</surname><given-names>IV</given-names></string-name>, <string-name name-style="western"><surname>Borkham&#8208;Kamphorst</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Zok</surname><given-names>S</given-names></string-name>, et&#160;al. <article-title>Platelet&#8208;derived growth factor (PDGF)&#8208;C neutralization reveals differential roles of PDGF receptors in liver and kidney fibrosis</article-title>. <source>Am J Pathol</source>. <year>2013</year>;<volume>182</volume>(<issue>1</issue>):<fpage>107</fpage>&#8208;<lpage>117</lpage>.<pub-id pub-id-type="pmid">23141925</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ajpath.2012.09.006</pub-id></mixed-citation></ref><ref id="ame270053-bib-0065"><label>65</label><mixed-citation publication-type="journal" id="ame270053-cit-0065"><string-name name-style="western"><surname>Wang</surname><given-names>BY</given-names></string-name>, <string-name name-style="western"><surname>Yang</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Fan</surname><given-names>YY</given-names></string-name>, et&#160;al. <article-title>3&#8208;methyladenine ameliorates liver fibrosis through autophagy regulated by the NF&#8208;&#954;B signaling pathways on hepatic stellate cell</article-title>. <source>Oncotarget</source>. <year>2017</year>;<volume>8</volume>(<issue>64</issue>):<fpage>107603</fpage>&#8208;<lpage>107611</lpage>.<pub-id pub-id-type="pmid">29296191</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.18632/oncotarget.22539</pub-id><pub-id pub-id-type="pmcid">PMC5746093</pub-id></mixed-citation></ref><ref id="ame270053-bib-0066"><label>66</label><mixed-citation publication-type="journal" id="ame270053-cit-0066"><string-name name-style="western"><surname>Wang</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>J</given-names></string-name>, et&#160;al. <article-title>Stiffness sensing via Piezo1 enhances macrophage efferocytosis and promotes the resolution of liver fibrosis</article-title>. <source>Sci Adv</source>. <year>2024</year>;<volume>10</volume>(<issue>23</issue>);<elocation-id>eadn3289</elocation-id>. doi:<pub-id pub-id-type="doi">10.1126/sciadv.adn3289</pub-id><pub-id pub-id-type="pmid">38838160</pub-id><pub-id pub-id-type="pmcid">PMC11152137</pub-id></mixed-citation></ref><ref id="ame270053-bib-0067"><label>67</label><mixed-citation publication-type="journal" id="ame270053-cit-0067"><string-name name-style="western"><surname>Parthasarathy</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Revelo</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Malhi</surname><given-names>H</given-names></string-name>. <article-title>Pathogenesis of nonalcoholic steatohepatitis: An overview</article-title>. <source>Hepatol Commun</source>. <year>2020</year>;<volume>4</volume>(<issue>4</issue>):<fpage>478</fpage>&#8208;<lpage>492</lpage>.<pub-id pub-id-type="pmid">32258944</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/hep4.1479</pub-id><pub-id pub-id-type="pmcid">PMC7109346</pub-id></mixed-citation></ref><ref id="ame270053-bib-0068"><label>68</label><mixed-citation publication-type="journal" id="ame270053-cit-0068"><string-name name-style="western"><surname>Henderson</surname><given-names>NC</given-names></string-name>, <string-name name-style="western"><surname>Rieder</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Wynn</surname><given-names>TA</given-names></string-name>. <article-title>Fibrosis: from mechanisms to medicines</article-title>. <source>Nature</source>. <year>2020</year>;<volume>587</volume>(<issue>7835</issue>):<fpage>555</fpage>&#8208;<lpage>566</lpage>.<pub-id pub-id-type="pmid">33239795</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41586-020-2938-9</pub-id><pub-id pub-id-type="pmcid">PMC8034822</pub-id></mixed-citation></ref><ref id="ame270053-bib-0069"><label>69</label><mixed-citation publication-type="journal" id="ame270053-cit-0069"><string-name name-style="western"><surname>Xu</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Vujic</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Bianco</surname><given-names>V</given-names></string-name>, et&#160;al. <article-title>Lipid&#8208;associated macrophages between aggravation and alleviation of metabolic diseases</article-title>. <source>Trends Endocrinol Metab</source>. <year>2024</year>;<volume>35</volume>(<issue>11</issue>):<fpage>981</fpage>&#8208;<lpage>995</lpage>.<pub-id pub-id-type="pmid">38705759</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.tem.2024.04.009</pub-id></mixed-citation></ref><ref id="ame270053-bib-0070"><label>70</label><mixed-citation publication-type="journal" id="ame270053-cit-0070"><string-name name-style="western"><surname>Ganguly</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Rosenthal</surname><given-names>SB</given-names></string-name>, <string-name name-style="western"><surname>Ishizuka</surname><given-names>K</given-names></string-name>, et&#160;al. <article-title>Lipid&#8208; associated macrophages' promotion of fibrosis resolution during MASH regression requires TREM2</article-title>. <source>Proc Natl Acad Sci USA</source>. <year>2024</year>;<volume>121</volume>(<issue>35</issue>);<elocation-id>e2405746121</elocation-id>. doi:<pub-id pub-id-type="doi">10.1073/pnas.2405746121</pub-id><pub-id pub-id-type="pmid">39172787</pub-id><pub-id pub-id-type="pmcid">PMC11363294</pub-id></mixed-citation></ref><ref id="ame270053-bib-0071"><label>71</label><mixed-citation publication-type="journal" id="ame270053-cit-0071"><string-name name-style="western"><surname>Jaitin</surname><given-names>DA</given-names></string-name>, <string-name name-style="western"><surname>Adlung</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Thaiss</surname><given-names>CA</given-names></string-name>, et&#160;al. <article-title>Lipid&#8208;associated macrophages control metabolic homeostasis in a Trem2&#8208;dependent manner</article-title>. <source>Cell</source>. <year>2019</year>;<volume>178</volume>(<issue>3</issue>):<fpage>686</fpage>.<pub-id pub-id-type="pmid">31257031</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cell.2019.05.054</pub-id><pub-id pub-id-type="pmcid">PMC7068689</pub-id></mixed-citation></ref><ref id="ame270053-bib-0072"><label>72</label><mixed-citation publication-type="journal" id="ame270053-cit-0072"><string-name name-style="western"><surname>Daemen</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Gainullina</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Kalugotla</surname><given-names>G</given-names></string-name>, et&#160;al. <article-title>Dynamic shifts in the composition of resident and recruited macrophages influence tissue remodeling in NASH</article-title>. <source>Cell Rep</source>. <year>2021</year>;<volume>34</volume>(<issue>2</issue>):<elocation-id>108626</elocation-id>.<pub-id pub-id-type="pmid">33440159</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.celrep.2020.108626</pub-id><pub-id pub-id-type="pmcid">PMC7877246</pub-id></mixed-citation></ref><ref id="ame270053-bib-0073"><label>73</label><mixed-citation publication-type="journal" id="ame270053-cit-0073"><string-name name-style="western"><surname>Guilliams</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Bonnardel</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Haest</surname><given-names>B</given-names></string-name>, et&#160;al. <article-title>Spatial proteogenomics reveals distinct and evolutionarily conserved hepatic macrophage niches</article-title>. <source>Cell</source>. <year>2022</year>;<volume>185</volume>(<issue>2</issue>):<fpage>379</fpage>.<pub-id pub-id-type="pmid">35021063</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cell.2021.12.018</pub-id><pub-id pub-id-type="pmcid">PMC8809252</pub-id></mixed-citation></ref><ref id="ame270053-bib-0074"><label>74</label><mixed-citation publication-type="journal" id="ame270053-cit-0074"><string-name name-style="western"><surname>Wang</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>He</surname><given-names>Q</given-names></string-name>, <string-name name-style="western"><surname>Zhou</surname><given-names>C</given-names></string-name>, et&#160;al. <article-title>Prolonged hypernutrition impairs TREM2&#8208;dependent efferocytosis to license chronic liver inflammation and NASH development</article-title>. <source>Immunity</source>. <year>2023</year>;<volume>56</volume>(<issue>1</issue>):<fpage>58</fpage>.<pub-id pub-id-type="pmid">36521495</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.immuni.2022.11.013</pub-id><pub-id pub-id-type="pmcid">PMC9839616</pub-id></mixed-citation></ref><ref id="ame270053-bib-0075"><label>75</label><mixed-citation publication-type="journal" id="ame270053-cit-0075"><string-name name-style="western"><surname>Li</surname><given-names>D&#8208;P</given-names></string-name>, <string-name name-style="western"><surname>Huang</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Kan</surname><given-names>R&#8208;R</given-names></string-name>, et&#160;al. <article-title>LILRB2/PirB mediates macrophage recruitment in fibrogenesis of nonalcoholic steatohepatitis</article-title>. <source>Nat Commun</source>. <year>2023</year>;<volume>14</volume>(<issue>1</issue>);<elocation-id>4436</elocation-id>. doi:<pub-id pub-id-type="doi">10.1038/s41467-023-40183-3</pub-id><pub-id pub-id-type="pmid">37481670</pub-id><pub-id pub-id-type="pmcid">PMC10363120</pub-id></mixed-citation></ref><ref id="ame270053-bib-0076"><label>76</label><mixed-citation publication-type="journal" id="ame270053-cit-0076"><string-name name-style="western"><surname>Vegting</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Jongejan</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Neele</surname><given-names>AE</given-names></string-name>, et&#160;al. <article-title>Infiltrative classical monocyte&#8208;derived and SPP1 lipid&#8208;associated macrophages mediate inflammation and fibrosis in ANCA&#8208;associated glomerulonephritis</article-title>. <source>Nephrol Dial Transplant</source>. <year>2025</year>. doi:<pub-id pub-id-type="doi">10.1093/ndt/gfae292</pub-id><pub-id pub-id-type="pmid">39694817</pub-id></mixed-citation></ref><ref id="ame270053-bib-0077"><label>77</label><mixed-citation publication-type="journal" id="ame270053-cit-0077"><string-name name-style="western"><surname>Jiang</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Yu</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Hu</surname><given-names>T</given-names></string-name>, et&#160;al. <article-title>Unveiling macrophage diversity in myocardial ischemia&#8208;reperfusion injury: identification of a distinct lipid&#8208;associated macrophage subset</article-title>. <source>Front Immunol</source>. <year>2024</year>;<volume>15</volume>:<elocation-id>1335333</elocation-id>. doi:<pub-id pub-id-type="doi">10.3389/fimmu.2024.1335333</pub-id><pub-id pub-id-type="pmid">38449872</pub-id><pub-id pub-id-type="pmcid">PMC10915075</pub-id></mixed-citation></ref><ref id="ame270053-bib-0078"><label>78</label><mixed-citation publication-type="journal" id="ame270053-cit-0078"><string-name name-style="western"><surname>Hou</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Cui</surname><given-names>P</given-names></string-name>, et&#160;al. <article-title>TREM2 sustains macrophage&#8208;hepatocyte metabolic coordination in nonalcoholic fatty liver disease and sepsis</article-title>. <source>J Clin Invest</source>. <year>2021</year>;<volume>131</volume>(<issue>4</issue>):<elocation-id>e135197</elocation-id>. doi:<pub-id pub-id-type="doi">10.1172/JCI135197</pub-id><pub-id pub-id-type="pmid">33586673</pub-id><pub-id pub-id-type="pmcid">PMC7880419</pub-id></mixed-citation></ref><ref id="ame270053-bib-0079"><label>79</label><mixed-citation publication-type="journal" id="ame270053-cit-0079"><string-name name-style="western"><surname>Zhang</surname><given-names>Q</given-names></string-name>, <string-name name-style="western"><surname>Hu</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Feng</surname><given-names>J</given-names></string-name>, et&#160;al. <article-title>Anti&#8208;inflammatory mechanisms of neutrophil membrane&#8208;coated nanoparticles without drug loading</article-title>. <source>J Control Release</source>. <year>2024</year>;<volume>369</volume>:<fpage>12</fpage>&#8208;<lpage>24</lpage>.<pub-id pub-id-type="pmid">38508526</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jconrel.2024.03.030</pub-id></mixed-citation></ref><ref id="ame270053-bib-0080"><label>80</label><mixed-citation publication-type="journal" id="ame270053-cit-0080"><string-name name-style="western"><surname>Zhang</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Tang</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Torres</surname><given-names>L</given-names></string-name>, et&#160;al. <article-title>Cell surface RNAs control neutrophil recruitment</article-title>. <source>Cell</source>. <year>2024</year>;<volume>187</volume>(<issue>4</issue>):<fpage>846</fpage>&#8211;<lpage>860</lpage>.<pub-id pub-id-type="pmid">38262409</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cell.2023.12.033</pub-id><pub-id pub-id-type="pmcid">PMC10922858</pub-id></mixed-citation></ref><ref id="ame270053-bib-0081"><label>81</label><mixed-citation publication-type="journal" id="ame270053-cit-0081"><string-name name-style="western"><surname>Mridha</surname><given-names>AR</given-names></string-name>, <string-name name-style="western"><surname>Wree</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Robertson</surname><given-names>AAB</given-names></string-name>, et&#160;al. <article-title>NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice</article-title>. <source>J Hepatol</source>. <year>2017</year>;<volume>66</volume>(<issue>5</issue>):<fpage>1037</fpage>&#8208;<lpage>1046</lpage>.<pub-id pub-id-type="pmid">28167322</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jhep.2017.01.022</pub-id><pub-id pub-id-type="pmcid">PMC6536116</pub-id></mixed-citation></ref><ref id="ame270053-bib-0082"><label>82</label><mixed-citation publication-type="journal" id="ame270053-cit-0082"><string-name name-style="western"><surname>Lai</surname><given-names>J&#8208;L</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>Y&#8208;H</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>C</given-names></string-name>, et&#160;al. <article-title>Indirubin inhibits LPS&#8208;induced inflammation <italic toggle="yes">via</italic> TLR4 abrogation mediated by the NF&#8208;kB and MAPK signaling pathways</article-title>. <source>Inflammation</source>. <year>2017</year>;<volume>40</volume>(<issue>1</issue>):<fpage>1</fpage>&#8208;<lpage>12</lpage>.<pub-id pub-id-type="pmid">27718095</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s10753-016-0447-7</pub-id></mixed-citation></ref><ref id="ame270053-bib-0083"><label>83</label><mixed-citation publication-type="journal" id="ame270053-cit-0083"><string-name name-style="western"><surname>Tohme</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Yazdani</surname><given-names>HO</given-names></string-name>, <string-name name-style="western"><surname>Al&#8208;Khafaji</surname><given-names>AB</given-names></string-name>, et&#160;al. <article-title>Neutrophil extracellular traps promote the development and progression of liver metastases after surgical stress</article-title>. <source>Cancer Res</source>. <year>2016</year>;<volume>76</volume>(<issue>6</issue>):<fpage>1367</fpage>&#8208;<lpage>1380</lpage>.<pub-id pub-id-type="pmid">26759232</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1158/0008-5472.CAN-15-1591</pub-id><pub-id pub-id-type="pmcid">PMC4794393</pub-id></mixed-citation></ref><ref id="ame270053-bib-0084"><label>84</label><mixed-citation publication-type="journal" id="ame270053-cit-0084"><string-name name-style="western"><surname>van der Windt</surname><given-names>DJ</given-names></string-name>, <string-name name-style="western"><surname>Sud</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>H</given-names></string-name>, et&#160;al. <article-title>Neutrophil extracellular traps promote inflammation and development of hepatocellular carcinoma in nonalcoholic steatohepatitis</article-title>. <source>Hepatology</source>. <year>2018</year>;<volume>68</volume>(<issue>4</issue>):<fpage>1347</fpage>&#8208;<lpage>1360</lpage>.<pub-id pub-id-type="pmid">29631332</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/hep.29914</pub-id><pub-id pub-id-type="pmcid">PMC6173613</pub-id></mixed-citation></ref><ref id="ame270053-bib-0085"><label>85</label><mixed-citation publication-type="journal" id="ame270053-cit-0085"><string-name name-style="western"><surname>Dokumacioglu</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Iskender</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Kapakin</surname><given-names>KAT</given-names></string-name>, et&#160;al. <article-title>Effect of betulinic acid administration on TLR&#8208;9/NF&#8208;&#954;B /IL&#8208;18 levels in experimental liver injury</article-title>. <source>Turk J Med Sci</source>. <year>2021</year>;<volume>51</volume>(<issue>3</issue>):<fpage>1544</fpage>&#8208;<lpage>1553</lpage>.<pub-id pub-id-type="pmid">33773522</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3906/sag-2004-184</pub-id><pub-id pub-id-type="pmcid">PMC8283446</pub-id></mixed-citation></ref><ref id="ame270053-bib-0086"><label>86</label><mixed-citation publication-type="journal" id="ame270053-cit-0086"><string-name name-style="western"><surname>Xia</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Xiong</surname><given-names>Q</given-names></string-name>, et&#160;al. <article-title>Neutrophil extracellular traps promote MASH fibrosis by metabolic reprogramming of hepatic stellate cells</article-title>. <source>Hepatology</source>. <year>2024</year>;<volume>81</volume>(<issue>3</issue>):<fpage>947</fpage>&#8211;<lpage>961</lpage>.<pub-id pub-id-type="pmid">38266270</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/HEP.0000000000000762</pub-id><pub-id pub-id-type="pmcid">PMC11881075</pub-id></mixed-citation></ref><ref id="ame270053-bib-0087"><label>87</label><mixed-citation publication-type="journal" id="ame270053-cit-0087"><string-name name-style="western"><surname>Klion</surname><given-names>AD</given-names></string-name>, <string-name name-style="western"><surname>Nutman</surname><given-names>TB</given-names></string-name>. <article-title>The role of eosinophils in host defense against helminth parasites</article-title>. <source>J Allergy Clin Immunol</source>. <year>2004</year>;<volume>113</volume>(<issue>1</issue>):<fpage>30</fpage>&#8208;<lpage>37</lpage>.<pub-id pub-id-type="pmid">14713904</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jaci.2003.10.050</pub-id></mixed-citation></ref><ref id="ame270053-bib-0088"><label>88</label><mixed-citation publication-type="journal" id="ame270053-cit-0088"><string-name name-style="western"><surname>Krishack</surname><given-names>PA</given-names></string-name>, <string-name name-style="western"><surname>Hollinger</surname><given-names>MK</given-names></string-name>, <string-name name-style="western"><surname>Kuzel</surname><given-names>TG</given-names></string-name>, et&#160;al. <article-title>IL&#8208;33&#8208;mediated eosinophilia protects against acute lung injury</article-title>. <source>Am J Respir Cell Mol Biol</source>. <year>2021</year>;<volume>64</volume>(<issue>5</issue>):<fpage>569</fpage>&#8208;<lpage>578</lpage>.<pub-id pub-id-type="pmid">33571420</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1165/rcmb.2020-0166OC</pub-id><pub-id pub-id-type="pmcid">PMC8086044</pub-id></mixed-citation></ref><ref id="ame270053-bib-0089"><label>89</label><mixed-citation publication-type="journal" id="ame270053-cit-0089"><string-name name-style="western"><surname>Xu</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Yang</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Wen</surname><given-names>Y</given-names></string-name>, et&#160;al. <article-title>Hepatic recruitment of eosinophils and their protective function during acute liver injury</article-title>. <source>J Hepatol</source>. <year>2022</year>;<volume>77</volume>(<issue>2</issue>):<fpage>344</fpage>&#8208;<lpage>352</lpage>.<pub-id pub-id-type="pmid">35259470</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jhep.2022.02.024</pub-id><pub-id pub-id-type="pmcid">PMC9308653</pub-id></mixed-citation></ref><ref id="ame270053-bib-0090"><label>90</label><mixed-citation publication-type="journal" id="ame270053-cit-0090"><string-name name-style="western"><surname>Yang</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Xu</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Atkins</surname><given-names>C</given-names></string-name>, et&#160;al. <article-title>Novel IL&#8208;4/HB&#8208;EGF&#8208;dependent crosstalk between eosinophils and macrophages controls liver regeneration after ischaemia and reperfusion injury</article-title>. <source>Gut</source>. <year>2024</year>;<volume>73</volume>(<issue>9</issue>):<fpage>1543</fpage>&#8208;<lpage>1553</lpage>.<pub-id pub-id-type="pmid">38724220</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/gutjnl-2024-332033</pub-id><pub-id pub-id-type="pmcid">PMC11347249</pub-id></mixed-citation></ref><ref id="ame270053-bib-0091"><label>91</label><mixed-citation publication-type="journal" id="ame270053-cit-0091"><string-name name-style="western"><surname>Sumpter</surname><given-names>TL</given-names></string-name>, <string-name name-style="western"><surname>Lunz</surname><given-names>JG</given-names><suffix>3rd</suffix></string-name>, <string-name name-style="western"><surname>Castellaneta</surname><given-names>A</given-names></string-name>, et&#160;al. <article-title>Dendritic cell immunobiology in relation to liver transplant outcome</article-title>. <source>Front Biosci (Elite Ed)</source>. <year>2009</year>;<volume>1</volume>(<issue>1</issue>):<fpage>99</fpage>&#8208;<lpage>114</lpage>.<pub-id pub-id-type="pmid">19482629</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2741/E11</pub-id></mixed-citation></ref><ref id="ame270053-bib-0092"><label>92</label><mixed-citation publication-type="journal" id="ame270053-cit-0092"><string-name name-style="western"><surname>Lau</surname><given-names>AH</given-names></string-name>, <string-name name-style="western"><surname>Thomson</surname><given-names>AW</given-names></string-name>. <article-title>Dendritic cells and immune regulation in the liver</article-title>. <source>Gut</source>. <year>2003</year>;<volume>52</volume>(<issue>2</issue>):<fpage>307</fpage>&#8208;<lpage>314</lpage>.<pub-id pub-id-type="pmid">12524419</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/gut.52.2.307</pub-id><pub-id pub-id-type="pmcid">PMC1774973</pub-id></mixed-citation></ref><ref id="ame270053-bib-0093"><label>93</label><mixed-citation publication-type="journal" id="ame270053-cit-0093"><string-name name-style="western"><surname>Thomson</surname><given-names>AW</given-names></string-name>, <string-name name-style="western"><surname>Knolle</surname><given-names>PA</given-names></string-name>. <article-title>Antigen&#8208;presenting cell function in the tolerogenic liver environment</article-title>. <source>Nat Rev Immunol</source>. <year>2010</year>;<volume>10</volume>(<issue>11</issue>):<fpage>753</fpage>&#8208;<lpage>766</lpage>.<pub-id pub-id-type="pmid">20972472</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nri2858</pub-id></mixed-citation></ref><ref id="ame270053-bib-0094"><label>94</label><mixed-citation publication-type="journal" id="ame270053-cit-0094"><string-name name-style="western"><surname>Ramos</surname><given-names>MI</given-names></string-name>, <string-name name-style="western"><surname>Tak</surname><given-names>PP</given-names></string-name>, <string-name name-style="western"><surname>Lebre</surname><given-names>MC</given-names></string-name>. <article-title>Fms&#8208;like tyrosine kinase 3 ligand&#8208;dependent dendritic cells in autoimmune inflammation</article-title>. <source>Autoimmun Rev</source>. <year>2014</year>;<volume>13</volume>(<issue>2</issue>):<fpage>117</fpage>&#8208;<lpage>124</lpage>.<pub-id pub-id-type="pmid">24113138</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.autrev.2013.09.010</pub-id></mixed-citation></ref><ref id="ame270053-bib-0095"><label>95</label><mixed-citation publication-type="journal" id="ame270053-cit-0095"><string-name name-style="western"><surname>Lutz</surname><given-names>MB</given-names></string-name>, <string-name name-style="western"><surname>Strobl</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Schuler</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Romani</surname><given-names>N</given-names></string-name>. <article-title>GM&#8208;CSF monocyte&#8208;derived cells and Langerhans cells As part of the dendritic cell family</article-title>. <source>Front Immunol</source>. <year>2017</year>;<volume>8</volume>:<elocation-id>1388</elocation-id>.<pub-id pub-id-type="pmid">29109731</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fimmu.2017.01388</pub-id><pub-id pub-id-type="pmcid">PMC5660299</pub-id></mixed-citation></ref><ref id="ame270053-bib-0096"><label>96</label><mixed-citation publication-type="journal" id="ame270053-cit-0096"><string-name name-style="western"><surname>Laffont</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Seillet</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Guery</surname><given-names>J&#8208;C</given-names></string-name>. <article-title>Estrogen receptor&#8208;dependent regulation of dendritic cell development and function</article-title>. <source>Front Immunol</source>. <year>2017</year>;<volume>8</volume>:<fpage>108</fpage>.<pub-id pub-id-type="pmid">28239379</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fimmu.2017.00108</pub-id><pub-id pub-id-type="pmcid">PMC5300975</pub-id></mixed-citation></ref><ref id="ame270053-bib-0097"><label>97</label><mixed-citation publication-type="journal" id="ame270053-cit-0097"><string-name name-style="western"><surname>Yang</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Kang</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Ha</surname><given-names>Y</given-names></string-name>, et&#160;al. <article-title>High serum IL&#8208;6 correlates with reduced clinical benefit of atezolizumab and bevacizumab in unresectable hepatocellular carcinoma</article-title>. <source>JHEP Rep</source>. <year>2023</year>;<volume>5</volume>(<issue>4</issue>):<elocation-id>100672</elocation-id>.<pub-id pub-id-type="pmid">36866388</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jhepr.2023.100672</pub-id><pub-id pub-id-type="pmcid">PMC9972403</pub-id></mixed-citation></ref><ref id="ame270053-bib-0098"><label>98</label><mixed-citation publication-type="journal" id="ame270053-cit-0098"><string-name name-style="western"><surname>Jarido</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Kennedy</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Hargrove</surname><given-names>L</given-names></string-name>, et&#160;al. <article-title>The emerging role of mast cells in liver disease</article-title>. <source>Am J Physiol Gastrointest Liver Physiol</source>. <year>2017</year>;<volume>313</volume>(<issue>2</issue>):<fpage>G89</fpage>&#8208;<lpage>G101</lpage>.<pub-id pub-id-type="pmid">28473331</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1152/ajpgi.00333.2016</pub-id><pub-id pub-id-type="pmcid">PMC5582878</pub-id></mixed-citation></ref><ref id="ame270053-bib-0099"><label>99</label><mixed-citation publication-type="journal" id="ame270053-cit-0099"><string-name name-style="western"><surname>Lombardo</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Broadwater</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Collins</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Cebe</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Brady</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Harrison</surname><given-names>S</given-names></string-name>. <article-title>Hepatic mast cell concentration directly correlates to stage of fibrosis in NASH</article-title>. <source>Hum Pathol</source>. <year>2019</year>;<volume>86</volume>:<fpage>129</fpage>&#8208;<lpage>135</lpage>.<pub-id pub-id-type="pmid">30597154</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.humpath.2018.11.029</pub-id></mixed-citation></ref><ref id="ame270053-bib-0100"><label>100</label><mixed-citation publication-type="journal" id="ame270053-cit-0100"><string-name name-style="western"><surname>Gieseck</surname><given-names>RL</given-names><suffix>III</suffix></string-name>, <string-name name-style="western"><surname>Wilson</surname><given-names>MS</given-names></string-name>, <string-name name-style="western"><surname>Wynn</surname><given-names>TA</given-names></string-name>. <article-title>Type 2 immunity in tissue repair and fibrosis</article-title>. <source>Nat Rev Immunol</source>. <year>2018</year>;<volume>18</volume>(<issue>1</issue>):<fpage>62</fpage>&#8208;<lpage>76</lpage>.<pub-id pub-id-type="pmid">28853443</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nri.2017.90</pub-id></mixed-citation></ref><ref id="ame270053-bib-0101"><label>101</label><mixed-citation publication-type="journal" id="ame270053-cit-0101"><string-name name-style="western"><surname>Min</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Prout</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Hu&#8208;Li</surname><given-names>J</given-names></string-name>, et&#160;al. <article-title>Basophils produce IL&#8208;4 and accumulate in tissues after infection with a Th2&#8208;inducing parasite</article-title>. <source>J Exp Med</source>. <year>2004</year>;<volume>200</volume>(<issue>4</issue>):<fpage>507</fpage>&#8208;<lpage>517</lpage>.<pub-id pub-id-type="pmid">15314076</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1084/jem.20040590</pub-id><pub-id pub-id-type="pmcid">PMC2211939</pub-id></mixed-citation></ref><ref id="ame270053-bib-0102"><label>102</label><mixed-citation publication-type="journal" id="ame270053-cit-0102"><string-name name-style="western"><surname>Jiang</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>H</given-names></string-name>. <article-title>Macrophage subsets at the maternal&#8208;fetal interface</article-title>. <source>Cell Mol Immunol</source>. <year>2020</year>;<volume>17</volume>(<issue>8</issue>):<fpage>889</fpage>&#8208;<lpage>891</lpage>.<pub-id pub-id-type="pmid">32382125</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41423-020-0435-6</pub-id><pub-id pub-id-type="pmcid">PMC7203721</pub-id></mixed-citation></ref><ref id="ame270053-bib-0103"><label>103</label><mixed-citation publication-type="journal" id="ame270053-cit-0103"><string-name name-style="western"><surname>Vidyarthi</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Agnihotri</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Khan</surname><given-names>N</given-names></string-name>, et&#160;al. <article-title>Predominance of M2 macrophages in gliomas leads to the suppression of local and systemic immunity</article-title>. <source>Cancer Immunol Immunother</source>. <year>2019</year>;<volume>68</volume>(<issue>12</issue>):<fpage>1995</fpage>&#8208;<lpage>2004</lpage>.<pub-id pub-id-type="pmid">31690954</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00262-019-02423-8</pub-id><pub-id pub-id-type="pmcid">PMC11028103</pub-id></mixed-citation></ref><ref id="ame270053-bib-0104"><label>104</label><mixed-citation publication-type="journal" id="ame270053-cit-0104"><string-name name-style="western"><surname>McKell</surname><given-names>MC</given-names></string-name>, <string-name name-style="western"><surname>Crowther</surname><given-names>RR</given-names></string-name>, <string-name name-style="western"><surname>Schmidt</surname><given-names>SM</given-names></string-name>, et&#160;al. <article-title>Promotion of anti&#8208;tuberculosis macrophage activity by L&#8208;arginine in the absence of nitric oxide</article-title>. <source>Front Immunol</source>. <year>2021</year>;<volume>12</volume>:<elocation-id>653571</elocation-id>.<pub-id pub-id-type="pmid">34054815</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fimmu.2021.653571</pub-id><pub-id pub-id-type="pmcid">PMC8160513</pub-id></mixed-citation></ref><ref id="ame270053-bib-0105"><label>105</label><mixed-citation publication-type="journal" id="ame270053-cit-0105"><string-name name-style="western"><surname>He</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Jia</surname><given-names>X</given-names></string-name>, et&#160;al. <article-title>Glycolytic reprogramming controls periodontitis&#8208;associated macrophage pyroptosis via AMPK/SIRT1/NF&#8208;&#954;B signaling pathway</article-title>. <source>Int Immunopharmacol</source>. <year>2023</year>;<volume>119</volume>:<elocation-id>110192</elocation-id>.<pub-id pub-id-type="pmid">37068341</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.intimp.2023.110192</pub-id></mixed-citation></ref><ref id="ame270053-bib-0106"><label>106</label><mixed-citation publication-type="journal" id="ame270053-cit-0106"><string-name name-style="western"><surname>Wang</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Han</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>H</given-names></string-name>, et&#160;al. <article-title>Role of HIF&#8208;1alpha in hydrogen&#8208;induced inhibition of lipopolysaccharide&#8208;induced inflammatory responses in mouse macrophages</article-title>. <source>Chin J Anesthesiol</source>. <year>2020</year>;<volume>40</volume>(<issue>7</issue>):<fpage>881</fpage>&#8208;<lpage>884</lpage>.</mixed-citation></ref><ref id="ame270053-bib-0107"><label>107</label><mixed-citation publication-type="journal" id="ame270053-cit-0107"><string-name name-style="western"><surname>Mendoza&#8208;Reinoso</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Schnepp</surname><given-names>PM</given-names></string-name>, <string-name name-style="western"><surname>Baek</surname><given-names>DY</given-names></string-name>, et&#160;al. <article-title>Bone marrow macrophages induce inflammation by efferocytosis of apoptotic prostate cancer cells via HIF&#8208;1&#945; stabilization</article-title>. <source>Cells</source>. <year>2022</year>;<volume>11</volume>(<issue>23</issue>):<elocation-id>3712</elocation-id>.<pub-id pub-id-type="pmid">36496973</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/cells11233712</pub-id><pub-id pub-id-type="pmcid">PMC9737180</pub-id></mixed-citation></ref><ref id="ame270053-bib-0108"><label>108</label><mixed-citation publication-type="journal" id="ame270053-cit-0108"><string-name name-style="western"><surname>Hutami</surname><given-names>IR</given-names></string-name>, <string-name name-style="western"><surname>Izawa</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Khurel&#8208;Ochir</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Sakamaki</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Iwasa</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Tanaka</surname><given-names>E</given-names></string-name>. <article-title>Macrophage motility in wound healing is regulated by HIF&#8208;1&#945; via S1P signaling</article-title>. <source>Int J Mol Sci</source>. <year>2021</year>;<volume>22</volume>(<issue>16</issue>):<elocation-id>8992</elocation-id>.<pub-id pub-id-type="pmid">34445695</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/ijms22168992</pub-id><pub-id pub-id-type="pmcid">PMC8396560</pub-id></mixed-citation></ref><ref id="ame270053-bib-0109"><label>109</label><mixed-citation publication-type="journal" id="ame270053-cit-0109"><string-name name-style="western"><surname>Yu</surname><given-names>Q</given-names></string-name>, <string-name name-style="western"><surname>Guo</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Zeng</surname><given-names>W</given-names></string-name>, et&#160;al. <article-title>Interactions between NLRP3 inflammasome and glycolysis in macrophages: new insights into chronic inflammation pathogenesis</article-title>. <source>Immun Inflamm Dis</source>. <year>2022</year>;<volume>10</volume>:<elocation-id>e581</elocation-id>. doi:<pub-id pub-id-type="doi">10.1002/iid3.581</pub-id><pub-id pub-id-type="pmid">34904398</pub-id><pub-id pub-id-type="pmcid">PMC8926505</pub-id></mixed-citation></ref><ref id="ame270053-bib-0110"><label>110</label><mixed-citation publication-type="journal" id="ame270053-cit-0110"><string-name name-style="western"><surname>Weng</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Gui</surname><given-names>L</given-names></string-name>, et&#160;al. <article-title>PKM2 promotes proinflammatory macrophage activation in ankylosing spondylitis</article-title>. <source>J Leukoc Biol</source>. <year>2023</year>;<volume>114</volume>(<issue>6</issue>):<fpage>595</fpage>&#8208;<lpage>603</lpage>.<pub-id pub-id-type="pmid">37192369</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/jleuko/qiad054</pub-id></mixed-citation></ref><ref id="ame270053-bib-0111"><label>111</label><mixed-citation publication-type="journal" id="ame270053-cit-0111"><string-name name-style="western"><surname>Zheng</surname><given-names>YW</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Xie</surname><given-names>JW</given-names></string-name>, et&#160;al. <article-title>Recombinant treponema pallidum protein Tp47 promoted the phagocytosis of macrophages by activating NLRP3 inflammasome induced by PKM2&#8208;dependent glycolysis</article-title>. <source>J Eur Acad Dermatol Venereol</source>. <year>2023</year>;<volume>37</volume>(<issue>10</issue>):<fpage>2067</fpage>&#8208;<lpage>2079</lpage>.<pub-id pub-id-type="pmid">37247195</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/jdv.19231</pub-id></mixed-citation></ref><ref id="ame270053-bib-0112"><label>112</label><mixed-citation publication-type="journal" id="ame270053-cit-0112"><string-name name-style="western"><surname>Yang</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Tao</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Wu</surname><given-names>Y</given-names></string-name>, et&#160;al. <article-title>Neutrophils promote the development of reparative macrophages mediated by ROS to orchestrate liver repair</article-title>. <source>Nat Commun</source>. <year>2019</year>;<volume>10</volume>(<issue>1</issue>):<fpage>1076</fpage>. doi:<pub-id pub-id-type="doi">10.1038/s41467-019-09046-8</pub-id><pub-id pub-id-type="pmid">30842418</pub-id><pub-id pub-id-type="pmcid">PMC6403250</pub-id></mixed-citation></ref><ref id="ame270053-bib-0113"><label>113</label><mixed-citation publication-type="journal" id="ame270053-cit-0113"><string-name name-style="western"><surname>Liu</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>Y</given-names></string-name>, et&#160;al. <article-title>S100A4 enhances protumor macrophage polarization by control of PPAR&#8208;&#947;&#8208;dependent induction of fatty acid oxidation</article-title>. <source>J Immunother Cancer</source>. <year>2021</year>;<volume>9</volume>(<issue>6</issue>):<elocation-id>e002548</elocation-id>. doi:<pub-id pub-id-type="doi">10.1136/jitc-2021-002548</pub-id><pub-id pub-id-type="pmid">34145030</pub-id><pub-id pub-id-type="pmcid">PMC8215236</pub-id></mixed-citation></ref><ref id="ame270053-bib-0114"><label>114</label><mixed-citation publication-type="journal" id="ame270053-cit-0114"><string-name name-style="western"><surname>Kruglov</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Jang</surname><given-names>IH</given-names></string-name>, <string-name name-style="western"><surname>Camell</surname><given-names>CD</given-names></string-name>. <article-title>Inflammaging and fatty acid oxidation in monocytes and macrophages</article-title>. <source>Immunometabolism</source>. <year>2024</year>;<volume>6</volume>(<issue>1</issue>):<elocation-id>e00038</elocation-id>.<pub-id pub-id-type="pmid">38249577</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/IN9.0000000000000038</pub-id><pub-id pub-id-type="pmcid">PMC10798594</pub-id></mixed-citation></ref><ref id="ame270053-bib-0115"><label>115</label><mixed-citation publication-type="journal" id="ame270053-cit-0115"><string-name name-style="western"><surname>Qiao</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Lv</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Tao</surname><given-names>Y</given-names></string-name>, et&#160;al. <article-title>Arctigenin disrupts NLRP3 inflammasome assembly in colonic macrophages via downregulating fatty acid oxidation to prevent colitis&#8208;associated cancer</article-title>. <source>Cancer Lett</source>. <year>2020</year>;<volume>491</volume>:<fpage>162</fpage>&#8208;<lpage>179</lpage>.<pub-id pub-id-type="pmid">32861708</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.canlet.2020.08.033</pub-id></mixed-citation></ref><ref id="ame270053-bib-0116"><label>116</label><mixed-citation publication-type="journal" id="ame270053-cit-0116"><string-name name-style="western"><surname>Hohensinner</surname><given-names>PJ</given-names></string-name>, <string-name name-style="western"><surname>Lenz</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Haider</surname><given-names>P</given-names></string-name>, et&#160;al. <article-title>Pharmacological inhibition of fatty acid oxidation reduces atherosclerosis progression by suppression of macrophage NLRP3 inflammasome activation</article-title>. <source>Biochem Pharmacol</source>. <year>2021</year>;<volume>190</volume>:<elocation-id>114634</elocation-id>.<pub-id pub-id-type="pmid">34058186</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.bcp.2021.114634</pub-id></mixed-citation></ref><ref id="ame270053-bib-0117"><label>117</label><mixed-citation publication-type="journal" id="ame270053-cit-0117"><string-name name-style="western"><surname>Wang</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Luo</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Wu</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Wan</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Wen</surname><given-names>Z</given-names></string-name>. <article-title>HMGB1 modulates macrophage metabolism and polarization in ulcerative colitis by inhibiting Cpt1a expression</article-title>. <source>Front Biosci (Landmark Ed)</source>. <year>2024</year>;<volume>29</volume>(<issue>11</issue>):<elocation-id>387</elocation-id>.<pub-id pub-id-type="pmid">39614449</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.31083/j.fbl2911387</pub-id></mixed-citation></ref><ref id="ame270053-bib-0118"><label>118</label><mixed-citation publication-type="journal" id="ame270053-cit-0118"><string-name name-style="western"><surname>Calle</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Munoz</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Sola</surname><given-names>A</given-names></string-name>, et&#160;al. <article-title>CPT1a gene expression reverses the inflammatory and anti&#8208;phagocytic effect of 7&#8208;ketocholesterol in RAW264.7 macrophages</article-title>. <source>Lipids Health Dis</source>. <year>2019</year>;<volume>18</volume>(<issue>1</issue>):<fpage>215</fpage>.<pub-id pub-id-type="pmid">31823799</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12944-019-1156-7</pub-id><pub-id pub-id-type="pmcid">PMC6902499</pub-id></mixed-citation></ref><ref id="ame270053-bib-0119"><label>119</label><mixed-citation publication-type="journal" id="ame270053-cit-0119"><string-name name-style="western"><surname>Lee</surname><given-names>J&#8208;H</given-names></string-name>, <string-name name-style="western"><surname>Phelan</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Shin</surname><given-names>M</given-names></string-name>, et&#160;al. <article-title>SREBP&#8208;1a&#8208;stimulated lipid synthesis is required for macrophage phagocytosis downstream of TLR4&#8208;directed mTORC1</article-title>. <source>Proc Natl Acad Sci USA</source>. <year>2018</year>;<volume>115</volume>(<issue>52</issue>):<fpage>E12228</fpage>&#8208;<lpage>E12234</lpage>.<pub-id pub-id-type="pmid">30530672</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.1813458115</pub-id><pub-id pub-id-type="pmcid">PMC6310840</pub-id></mixed-citation></ref><ref id="ame270053-bib-0120"><label>120</label><mixed-citation publication-type="journal" id="ame270053-cit-0120"><string-name name-style="western"><surname>Araki</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Nakagawa</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Saito</surname><given-names>H</given-names></string-name>, et&#160;al. <article-title>Hepatocyte&#8208; or macrophage&#8208;specific SREBP&#8208;1a deficiency in mice exacerbates methionine&#8208; and choline&#8208;deficient diet&#8208;induced nonalcoholic fatty liver disease</article-title>. <source>Am J Physiol Gastrointest Liver Physiol</source>. <year>2022</year>;<volume>323</volume>(<issue>6</issue>):<fpage>G627</fpage>&#8208;<lpage>G639</lpage>.<pub-id pub-id-type="pmid">36283088</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1152/ajpgi.00090.2022</pub-id></mixed-citation></ref><ref id="ame270053-bib-0121"><label>121</label><mixed-citation publication-type="journal" id="ame270053-cit-0121"><string-name name-style="western"><surname>Liu</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Yang</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Wu</surname><given-names>Z</given-names></string-name>. <article-title>The regulatory role of &#945;&#8208;ketoglutarate metabolism in macrophages</article-title>. <source>Mediat Inflamm</source>. <year>2021</year>;<volume>2021</volume>:<elocation-id>5577577</elocation-id>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1155/2021/5577577</pub-id><pub-id pub-id-type="pmcid">PMC8024083</pub-id><pub-id pub-id-type="pmid">33859536</pub-id></mixed-citation></ref><ref id="ame270053-bib-0122"><label>122</label><mixed-citation publication-type="journal" id="ame270053-cit-0122"><string-name name-style="western"><surname>Zhang</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Wan</surname><given-names>C</given-names></string-name>, et&#160;al. <article-title>NLRP3 inflammasome mediates M1 macrophage polarization and IL&#8208;1&#946; production in inflammatory root resorption</article-title>. <source>J Clin Periodontol</source>. <year>2020</year>;<volume>47</volume>(<issue>4</issue>):<fpage>451</fpage>&#8208;<lpage>460</lpage>.<pub-id pub-id-type="pmid">31976565</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/jcpe.13258</pub-id></mixed-citation></ref><ref id="ame270053-bib-0123"><label>123</label><mixed-citation publication-type="journal" id="ame270053-cit-0123"><string-name name-style="western"><surname>Hong</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Yu</surname><given-names>J&#8208;W</given-names></string-name>. <article-title>Prolonged exposure to lipopolysaccharide induces NLRP3&#8208;independent maturation and secretion of interleukin (IL)&#8208;1&#946; in macrophages</article-title>. <source>J Microbiol Biotechnol</source>. <year>2018</year>;<volume>28</volume>(<issue>1</issue>):<fpage>115</fpage>&#8208;<lpage>121</lpage>.<pub-id pub-id-type="pmid">29061031</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.4014/jmb.1709.09017</pub-id></mixed-citation></ref><ref id="ame270053-bib-0124"><label>124</label><mixed-citation publication-type="journal" id="ame270053-cit-0124"><string-name name-style="western"><surname>Wang</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>Q</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>S</given-names></string-name>, et&#160;al. <article-title>Serine synthesis sustains macrophage IL&#8208;1&#946; production via NAD<sup>+</sup>&#8208;dependent protein acetylation</article-title>. <source>Mol Cell</source>. <year>2024</year>;<volume>84</volume>(<issue>4</issue>):<fpage>744</fpage>&#8211;<lpage>759</lpage>.<pub-id pub-id-type="pmid">38266638</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.molcel.2024.01.002</pub-id></mixed-citation></ref><ref id="ame270053-bib-0125"><label>125</label><mixed-citation publication-type="journal" id="ame270053-cit-0125"><string-name name-style="western"><surname>Shan</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Hu</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Ni</surname><given-names>L</given-names></string-name>, et&#160;al. <article-title>Serine metabolism orchestrates macrophage polarization by regulating the IGF1&#8208;p38 axis</article-title>. <source>Cell Mol Immunol</source>. <year>2022</year>;<volume>19</volume>(<issue>11</issue>):<fpage>1263</fpage>&#8208;<lpage>1278</lpage>.<pub-id pub-id-type="pmid">36180780</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41423-022-00925-7</pub-id><pub-id pub-id-type="pmcid">PMC9622887</pub-id></mixed-citation></ref><ref id="ame270053-bib-0126"><label>126</label><mixed-citation publication-type="journal" id="ame270053-cit-0126"><string-name name-style="western"><surname>Li</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Cui</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Lin</surname><given-names>P</given-names></string-name>, et&#160;al. <article-title>Kupffer&#8208;cell&#8208;derived IL&#8208;6 is repurposed for hepatocyte dedifferentiation via activating progenitor genes from injury&#8208;specific enhancers</article-title>. <source>Cell Stem Cell</source>. <year>2023</year>;<volume>30</volume>(<issue>3</issue>):<fpage>283</fpage>.<pub-id pub-id-type="pmid">36787740</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.stem.2023.01.009</pub-id></mixed-citation></ref><ref id="ame270053-bib-0127"><label>127</label><mixed-citation publication-type="journal" id="ame270053-cit-0127"><string-name name-style="western"><surname>Carbonaro</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Huang</surname><given-names>H</given-names></string-name>, et&#160;al. <article-title>IL&#8208;6&#8208;GP130 signaling protects human hepatocytes against lipid droplet accumulation in humanized liver models</article-title>. <source>Sci Adv</source>. <year>2023</year>;<volume>9</volume>(<issue>15</issue>):<elocation-id>eadf4490</elocation-id>. doi:<pub-id pub-id-type="doi">10.1126/sciadv.adf4490</pub-id><pub-id pub-id-type="pmid">37058568</pub-id><pub-id pub-id-type="pmcid">PMC10104468</pub-id></mixed-citation></ref><ref id="ame270053-bib-0128"><label>128</label><mixed-citation publication-type="journal" id="ame270053-cit-0128"><string-name name-style="western"><surname>Wen</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Feng</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Wu</surname><given-names>H</given-names></string-name>, et&#160;al. <article-title>Defective initiation of liver regeneration in Osteopontin&#8208;deficient mice after partial hepatectomy due to insufficient activation of IL&#8208;6/Stat3 pathway</article-title>. <source>Int J Biol Sci</source>. <year>2015</year>;<volume>11</volume>(<issue>10</issue>):<fpage>1236</fpage>&#8208;<lpage>1247</lpage>.<pub-id pub-id-type="pmid">26327817</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.7150/ijbs.12118</pub-id><pub-id pub-id-type="pmcid">PMC4551759</pub-id></mixed-citation></ref><ref id="ame270053-bib-0129"><label>129</label><mixed-citation publication-type="journal" id="ame270053-cit-0129"><string-name name-style="western"><surname>Averilla</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Zhao</surname><given-names>J</given-names></string-name>, et&#160;al. <article-title>Kupffer cells undergo anti&#8208;inflammatory adaptive changes in the early phase of alcohol exposure</article-title>. <source>Hepatology</source>. <year>2020</year>;<volume>72</volume>:<fpage>175A</fpage>.</mixed-citation></ref><ref id="ame270053-bib-0130"><label>130</label><mixed-citation publication-type="journal" id="ame270053-cit-0130"><string-name name-style="western"><surname>Xia</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Lei</surname><given-names>W</given-names></string-name>, et&#160;al. <article-title>Advances in the role of STAT3 in macrophage polarization</article-title>. <source>Front Immunol</source>. <year>2023</year>;<volume>14</volume>:<elocation-id>1160719</elocation-id>.<pub-id pub-id-type="pmid">37081874</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fimmu.2023.1160719</pub-id><pub-id pub-id-type="pmcid">PMC10110879</pub-id></mixed-citation></ref><ref id="ame270053-bib-0131"><label>131</label><mixed-citation publication-type="journal" id="ame270053-cit-0131"><string-name name-style="western"><surname>Wu</surname><given-names>B&#8208;M</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>J&#8208;D</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>Y&#8208;H</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>J</given-names></string-name>. <article-title>Margatoxin mitigates CCl4&#8208;induced hepatic fibrosis in mice via macrophage polarization, cytokine secretion and STAT signaling</article-title>. <source>Int J Mol Med</source>. <year>2020</year>;<volume>45</volume>(<issue>1</issue>):<fpage>103</fpage>&#8208;<lpage>114</lpage>.<pub-id pub-id-type="pmid">31746414</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3892/ijmm.2019.4395</pub-id><pub-id pub-id-type="pmcid">PMC6889929</pub-id></mixed-citation></ref><ref id="ame270053-bib-0132"><label>132</label><mixed-citation publication-type="journal" id="ame270053-cit-0132"><string-name name-style="western"><surname>Zhang</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>X</given-names></string-name>, et&#160;al. <article-title>TGF&#8208;&#946; induces M2&#8208;like macrophage polarization via SNAIL&#8208;mediated suppression of a pro&#8208;inflammatory phenotype</article-title>. <source>Oncotarget</source>. <year>2016</year>;<volume>7</volume>(<issue>32</issue>):<fpage>52294</fpage>&#8208;<lpage>52306</lpage>.<pub-id pub-id-type="pmid">27418133</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.18632/oncotarget.10561</pub-id><pub-id pub-id-type="pmcid">PMC5239552</pub-id></mixed-citation></ref><ref id="ame270053-bib-0133"><label>133</label><mixed-citation publication-type="journal" id="ame270053-cit-0133"><string-name name-style="western"><surname>Kawakubo</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Miyagi</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Yokozeki</surname><given-names>Y</given-names></string-name>, et&#160;al. <article-title>Origin of M2 M&#966; and its macrophage polarization by TGF&#8208;&#946; in a mice intervertebral injury model</article-title>. <source>Int J Immunopathol Pharmacol</source>. <year>2022</year>;<volume>36</volume>:<elocation-id>03946320221103792</elocation-id>. doi:<pub-id pub-id-type="doi">10.1177/03946320221103792</pub-id><pub-id pub-id-type="pmid">35592891</pub-id><pub-id pub-id-type="pmcid">PMC9174651</pub-id></mixed-citation></ref><ref id="ame270053-bib-0134"><label>134</label><mixed-citation publication-type="journal" id="ame270053-cit-0134"><string-name name-style="western"><surname>Fan</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Qu</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Yuan</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Shi</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>G</given-names></string-name>. <article-title>Loureirin B accelerates diabetic wound healing by promoting TGF&#946;/Smad&#8208;dependent macrophage M2 polarization: A concerted analytical approach through single&#8208;cell RNA sequencing and experimental verification</article-title>. <source>Phytother Res</source>. <year>2024</year>. doi:<pub-id pub-id-type="doi">10.1002/ptr.8373</pub-id><pub-id pub-id-type="pmid">39532388</pub-id></mixed-citation></ref><ref id="ame270053-bib-0135"><label>135</label><mixed-citation publication-type="journal" id="ame270053-cit-0135"><string-name name-style="western"><surname>Wang</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Wu</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Huang</surname><given-names>Y</given-names></string-name>, et&#160;al. <article-title>IRF4 induces M1 macrophage polarization and aggravates ulcerative colitis progression by the Bcl6&#8208;dependent STAT3 pathway</article-title>. <source>Environ Toxicol</source>. <year>2024</year>;<volume>39</volume>(<issue>4</issue>):<fpage>2390</fpage>&#8208;<lpage>2404</lpage>.<pub-id pub-id-type="pmid">38164749</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/tox.24106</pub-id></mixed-citation></ref><ref id="ame270053-bib-0136"><label>136</label><mixed-citation publication-type="journal" id="ame270053-cit-0136"><string-name name-style="western"><surname>Miao</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Yong</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Zheng</surname><given-names>Z</given-names></string-name>, et&#160;al. <article-title>Artesunate inhibits neointimal hyperplasia by promoting IRF4 associated macrophage polarization</article-title>. <source>Adv Sci</source>. <year>2025</year>;<volume>12</volume>:<elocation-id>e2408992</elocation-id>. doi:<pub-id pub-id-type="doi">10.1002/advs.202408992</pub-id><pub-id pub-id-type="pmcid">PMC12097016</pub-id><pub-id pub-id-type="pmid">40126336</pub-id></mixed-citation></ref><ref id="ame270053-bib-0137"><label>137</label><mixed-citation publication-type="book" id="ame270053-cit-0137"><string-name name-style="western"><surname>Roeszer</surname><given-names>T</given-names></string-name>. <part-title>What is an M2 macrophage? Historical overview of the macrophage polarization model. The Th1/Th2 and M1/M2 paradigm, the arginine fork</part-title>. <source>M2 Macrophage</source>. Vol <volume>86</volume><publisher-name>Springer</publisher-name>; <year>2020</year>:<fpage>3</fpage>&#8208;<lpage>25</lpage>.</mixed-citation></ref><ref id="ame270053-bib-0138"><label>138</label><mixed-citation publication-type="journal" id="ame270053-cit-0138"><string-name name-style="western"><surname>Seidman</surname><given-names>JS</given-names></string-name>, <string-name name-style="western"><surname>Troutman</surname><given-names>TD</given-names></string-name>, <string-name name-style="western"><surname>Sakai</surname><given-names>M</given-names></string-name>, et&#160;al. <article-title>Niche&#8208;specific reprogramming of epigenetic landscapes drives myeloid cell diversity in nonalcoholic steatohepatitis</article-title>. <source>Immunity</source>. <year>2020</year>;<volume>52</volume>(<issue>6</issue>):<fpage>1057</fpage>.<pub-id pub-id-type="pmid">32362324</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.immuni.2020.04.001</pub-id><pub-id pub-id-type="pmcid">PMC7305990</pub-id></mixed-citation></ref><ref id="ame270053-bib-0139"><label>139</label><mixed-citation publication-type="journal" id="ame270053-cit-0139"><string-name name-style="western"><surname>Zhu</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Shang</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Tang</surname><given-names>Y</given-names></string-name>, et&#160;al. <article-title>Genome&#8208;wide profiling of H3K27ac identifies TDO2 as a pivotal therapeutic target in metabolic associated steatohepatitis liver disease</article-title>. <source>Adv Sci</source>. <year>2024</year>;<volume>11</volume>(<issue>45</issue>):<elocation-id>e2404224</elocation-id>. doi:<pub-id pub-id-type="doi">10.1002/advs.202404224</pub-id><pub-id pub-id-type="pmcid">PMC11615751</pub-id><pub-id pub-id-type="pmid">39364706</pub-id></mixed-citation></ref><ref id="ame270053-bib-0140"><label>140</label><mixed-citation publication-type="journal" id="ame270053-cit-0140"><string-name name-style="western"><surname>Wu</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Gong</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>Y</given-names></string-name>, et&#160;al. <article-title>SGK1 aggravates idiopathic pulmonary fibrosis by triggering H3k27ac&#8208;mediated macrophage reprogramming and disturbing immune homeostasis</article-title>. <source>Int J Biol Sci</source>. <year>2024</year>;<volume>20</volume>(<issue>3</issue>):<fpage>968</fpage>&#8208;<lpage>986</lpage>.<pub-id pub-id-type="pmid">38250161</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.7150/ijbs.90808</pub-id><pub-id pub-id-type="pmcid">PMC10797695</pub-id></mixed-citation></ref><ref id="ame270053-bib-0141"><label>141</label><mixed-citation publication-type="journal" id="ame270053-cit-0141"><string-name name-style="western"><surname>Fang</surname><given-names>J&#8208;Z</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>X&#8208;Y</given-names></string-name>, <string-name name-style="western"><surname>Hu</surname><given-names>TT</given-names></string-name>, <string-name name-style="western"><surname>Fan</surname><given-names>ZS</given-names></string-name>, <string-name name-style="western"><surname>Han</surname><given-names>ZG</given-names></string-name>. <article-title>Hepatocyte&#8208;specific Arid1a deficiency initiates mouse steatohepatitis and hepatocellular carcinoma</article-title>. <source>PLoS One</source>. <year>2015</year>;<volume>10</volume>(<issue>11</issue>):<elocation-id>e0143042</elocation-id>.<pub-id pub-id-type="pmid">26569409</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0143042</pub-id><pub-id pub-id-type="pmcid">PMC4646347</pub-id></mixed-citation></ref><ref id="ame270053-bib-0142"><label>142</label><mixed-citation publication-type="journal" id="ame270053-cit-0142"><string-name name-style="western"><surname>Li</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Huo</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Lin</surname><given-names>Z</given-names></string-name>, et&#160;al. <article-title>DNA hydroxymethylase 10&#8208;11 translocation 2 (TET2) inhibits mouse macrophage activation and polarization</article-title>. <source>Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi</source>. <year>2017</year>;<volume>33</volume>(<issue>9</issue>):<fpage>1165</fpage>&#8208;<lpage>1170</lpage>.<pub-id pub-id-type="pmid">29089070</pub-id></mixed-citation></ref><ref id="ame270053-bib-0143"><label>143</label><mixed-citation publication-type="journal" id="ame270053-cit-0143"><string-name name-style="western"><surname>Fan</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Tan</surname><given-names>L</given-names></string-name>, et&#160;al. <article-title>Tet2 modulates M2 macrophage polarization via mRNA 5&#8208;methylcytosine in allergic rhinitis</article-title>. <source>Int Immunopharmacol</source>. <year>2024</year>;<volume>143</volume>:<elocation-id>113495</elocation-id>.<pub-id pub-id-type="pmid">39486186</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.intimp.2024.113495</pub-id></mixed-citation></ref><ref id="ame270053-bib-0144"><label>144</label><mixed-citation publication-type="journal" id="ame270053-cit-0144"><string-name name-style="western"><surname>Ross</surname><given-names>JB</given-names></string-name>, <string-name name-style="western"><surname>Myers</surname><given-names>LM</given-names></string-name>, <string-name name-style="western"><surname>Noh</surname><given-names>JJ</given-names></string-name>, et&#160;al. <article-title>Depleting myeloid&#8208;biased haematopoietic stem cells rejuvenates aged immunity</article-title>. <source>Nature</source>. <year>2024</year>;<volume>628</volume>(<issue>8006</issue>):<fpage>162</fpage>.<pub-id pub-id-type="pmid">38538791</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41586-024-07238-x</pub-id><pub-id pub-id-type="pmcid">PMC11870232</pub-id></mixed-citation></ref><ref id="ame270053-bib-0145"><label>145</label><mixed-citation publication-type="journal" id="ame270053-cit-0145"><string-name name-style="western"><surname>Drechsler</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Soehnlein</surname><given-names>O</given-names></string-name>. <article-title>The complexity of arterial classical monocyte recruitment</article-title>. <source>J Innate Immun</source>. <year>2013</year>;<volume>5</volume>(<issue>4</issue>):<fpage>358</fpage>&#8208;<lpage>366</lpage>.<pub-id pub-id-type="pmid">23571485</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1159/000348795</pub-id><pub-id pub-id-type="pmcid">PMC6741506</pub-id></mixed-citation></ref><ref id="ame270053-bib-0146"><label>146</label><mixed-citation publication-type="journal" id="ame270053-cit-0146"><string-name name-style="western"><surname>Tacke</surname><given-names>F</given-names></string-name>. <article-title>Cenicriviroc for the treatment of non&#8208;alcoholic steatohepatitis and liver fibrosis</article-title>. <source>Expert Opin Investig Drugs</source>. <year>2018</year>;<volume>27</volume>(<issue>3</issue>):<fpage>301</fpage>&#8208;<lpage>311</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/13543784.2018.1442436</pub-id><pub-id pub-id-type="pmid">29448843</pub-id></mixed-citation></ref><ref id="ame270053-bib-0147"><label>147</label><mixed-citation publication-type="journal" id="ame270053-cit-0147"><string-name name-style="western"><surname>Soto</surname><given-names>MPD</given-names></string-name>, <string-name name-style="western"><surname>Lim</surname><given-names>JK</given-names></string-name>. <article-title>Evaluating the therapeutic potential of Cenicriviroc in the treatment of nonalcoholic steatohepatitis with fibrosis: A brief report on emerging data</article-title>. <source>Hepat Med</source>. <year>2020</year>;<volume>12</volume>:<fpage>115</fpage>&#8208;<lpage>123</lpage>.<pub-id pub-id-type="pmid">32884369</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2147/HMER.S230613</pub-id><pub-id pub-id-type="pmcid">PMC7434517</pub-id></mixed-citation></ref><ref id="ame270053-bib-0148"><label>148</label><mixed-citation publication-type="journal" id="ame270053-cit-0148"><string-name name-style="western"><surname>Theyab</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Algahtani</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Alsharif</surname><given-names>KF</given-names></string-name>, et&#160;al. <article-title>New insight into the mechanism of granulocyte colony&#8208;stimulating factor (G&#8208;CSF) that induces the mobilization of neutrophils</article-title>. <source>Hematology</source>. <year>2021</year>;<volume>26</volume>(<issue>1</issue>):<fpage>628</fpage>&#8208;<lpage>636</lpage>.<pub-id pub-id-type="pmid">34494505</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/16078454.2021.1965725</pub-id></mixed-citation></ref><ref id="ame270053-bib-0149"><label>149</label><mixed-citation publication-type="journal" id="ame270053-cit-0149"><string-name name-style="western"><surname>Mouchemore</surname><given-names>KA</given-names></string-name>, <string-name name-style="western"><surname>Anderson</surname><given-names>RL</given-names></string-name>, <string-name name-style="western"><surname>Hamilton</surname><given-names>JA</given-names></string-name>. <article-title>Neutrophils, G&#8208;CSF and their contribution to breast cancer metastasis</article-title>. <source>FEBS J</source>. <year>2018</year>;<volume>285</volume>(<issue>4</issue>):<fpage>665</fpage>&#8208;<lpage>679</lpage>.<pub-id pub-id-type="pmid">28834401</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/febs.14206</pub-id></mixed-citation></ref><ref id="ame270053-bib-0150"><label>150</label><mixed-citation publication-type="journal" id="ame270053-cit-0150"><string-name name-style="western"><surname>Ding</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Zhou</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Qian</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Yang</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Tang</surname><given-names>L</given-names></string-name>. <article-title>Trimetazidine inhibits liver fibrosis and hepatic stellate cell proliferation and blocks transforming growth factor&#8208;&#946; (TGF&#946;)/Smad signaling in&#160;vitro and in&#160;vivo</article-title>. <source>Bioengineered</source>. <year>2022</year>;<volume>13</volume>(<issue>3</issue>):<fpage>7147</fpage>&#8208;<lpage>7156</lpage>.<pub-id pub-id-type="pmid">35249457</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/21655979.2022.2047403</pub-id><pub-id pub-id-type="pmcid">PMC8973947</pub-id></mixed-citation></ref><ref id="ame270053-bib-0151"><label>151</label><mixed-citation publication-type="journal" id="ame270053-cit-0151"><string-name name-style="western"><surname>Xiang&#8208;An</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Guangmei</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Yong</surname><given-names>L</given-names></string-name>, et&#160;al. <article-title>Curcumin reduces Ly6Chi monocyte infiltration to protect against liver fibrosis by inhibiting Kupffer cells activation to reduce chemokines secretion</article-title>. <source>Biomed Pharmacother</source>. <year>2018</year>;<volume>106</volume>:<fpage>868</fpage>&#8208;<lpage>878</lpage>.<pub-id pub-id-type="pmid">30119257</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.biopha.2018.07.028</pub-id></mixed-citation></ref><ref id="ame270053-bib-0152"><label>152</label><mixed-citation publication-type="journal" id="ame270053-cit-0152"><string-name name-style="western"><surname>Zhang</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Sun</surname><given-names>W&#8208;Y</given-names></string-name>, <string-name name-style="western"><surname>Wu</surname><given-names>J&#8208;J</given-names></string-name>, et&#160;al. <article-title>Targeting the TGF&#8208;&#946; signaling pathway in liver diseases</article-title>. <source>Chinese Pharmacol Bull</source>. <year>2013</year>;<volume>29</volume>(<issue>11</issue>):<fpage>1489</fpage>&#8208;<lpage>1493</lpage>.</mixed-citation></ref><ref id="ame270053-bib-0153"><label>153</label><mixed-citation publication-type="journal" id="ame270053-cit-0153"><string-name name-style="western"><surname>Reiter</surname><given-names>FP</given-names></string-name>, <string-name name-style="western"><surname>Wimmer</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Wottke</surname><given-names>L</given-names></string-name>, et&#160;al. <article-title>Role of interleukin&#8208;1 and its antagonism of hepatic stellate cell proliferation and liver fibrosis in the Abcb4(&#8722;/&#8722;) mouse model</article-title>. <source>World J Hepatol</source>. <year>2016</year>;<volume>8</volume>(<issue>8</issue>):<fpage>401</fpage>&#8208;<lpage>410</lpage>.<pub-id pub-id-type="pmid">27004088</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.4254/wjh.v8.i8.401</pub-id><pub-id pub-id-type="pmcid">PMC4794530</pub-id></mixed-citation></ref><ref id="ame270053-bib-0154"><label>154</label><mixed-citation publication-type="journal" id="ame270053-cit-0154"><string-name name-style="western"><surname>Huang</surname><given-names>Y&#8208;H</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>M&#8208;H</given-names></string-name>, <string-name name-style="western"><surname>Guo</surname><given-names>Q&#8208;L</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>ZX</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>QD</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>XZ</given-names></string-name>. <article-title>Interleukin&#8208;10 induces senescence of activated hepatic stellate cells via STAT3&#8208;p53 pathway to attenuate liver fibrosis</article-title>. <source>Cell Signal</source>. <year>2020</year>;<volume>66</volume>:<elocation-id>109445</elocation-id>.<pub-id pub-id-type="pmid">31730896</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cellsig.2019.109445</pub-id></mixed-citation></ref><ref id="ame270053-bib-0155"><label>155</label><mixed-citation publication-type="journal" id="ame270053-cit-0155"><string-name name-style="western"><surname>Chou</surname><given-names>WY</given-names></string-name>, <string-name name-style="western"><surname>Lu</surname><given-names>CN</given-names></string-name>, <string-name name-style="western"><surname>Lee</surname><given-names>TH</given-names></string-name>, et&#160;al. <article-title>Electroporative interleukin&#8208;10 gene transfer ameliorates carbon tetrachlo&#8208;ride&#8208;induced murine liver fibrosis by MMP and TIMP modulation</article-title>. <source>Acta Pharmacol Sin</source>. <year>2006</year>;<volume>27</volume>(<issue>4</issue>):<fpage>469</fpage>&#8208;<lpage>476</lpage>.<pub-id pub-id-type="pmid">16539848</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1745-7254.2006.00304.x</pub-id></mixed-citation></ref><ref id="ame270053-bib-0156"><label>156</label><mixed-citation publication-type="journal" id="ame270053-cit-0156"><string-name name-style="western"><surname>Mahamid</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Paz</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Reuven</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Safadi</surname><given-names>R</given-names></string-name>. <article-title>Hepatotoxicity due to tocilizumab and anakinra in rheumatoid arthritis: two case reports</article-title>. <source>Int J Gen Med</source>. <year>2011</year>;<volume>4</volume>:<fpage>657</fpage>&#8208;<lpage>660</lpage>.<pub-id pub-id-type="pmid">21941451</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2147/IJGM.S23920</pub-id><pub-id pub-id-type="pmcid">PMC3177591</pub-id></mixed-citation></ref><ref id="ame270053-bib-0157"><label>157</label><mixed-citation publication-type="journal" id="ame270053-cit-0157"><string-name name-style="western"><surname>Mahamid</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Mader</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Safadi</surname><given-names>R</given-names></string-name>. <article-title>Hepatotoxicity of tocilizumab and anakinra in rheumatoid arthritis: management decisions</article-title>. <source>Clin Pharm</source>. <year>2011</year>;<volume>3</volume>:<fpage>39</fpage>&#8208;<lpage>43</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.2147/CPAA.S24004</pub-id><pub-id pub-id-type="pmcid">PMC3262392</pub-id><pub-id pub-id-type="pmid">22287855</pub-id></mixed-citation></ref><ref id="ame270053-bib-0158"><label>158</label><mixed-citation publication-type="journal" id="ame270053-cit-0158"><string-name name-style="western"><surname>Zhou</surname><given-names>GP</given-names></string-name>, <string-name name-style="western"><surname>Jiang</surname><given-names>YZ</given-names></string-name>, <string-name name-style="western"><surname>Sun</surname><given-names>LY</given-names></string-name>, <string-name name-style="western"><surname>Zhu</surname><given-names>ZJ</given-names></string-name>. <article-title>Therapeutic effect and safety of stem cell therapy for chronic liver disease: a systematic review and meta&#8208;analysis of randomized controlled trials</article-title>. <source>Stem Cell Res Ther</source>. <year>2020</year>;<volume>11</volume>(<issue>1</issue>):<fpage>419</fpage>.<pub-id pub-id-type="pmid">32977828</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s13287-020-01935-w</pub-id><pub-id pub-id-type="pmcid">PMC7519526</pub-id></mixed-citation></ref><ref id="ame270053-bib-0159"><label>159</label><mixed-citation publication-type="journal" id="ame270053-cit-0159"><string-name name-style="western"><surname>Liu</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Mao</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Xie</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Wei</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Yao</surname><given-names>J</given-names></string-name>. <article-title>Stem cells for treatment of liver fibrosis/cirrhosis: clinical progress and therapeutic potential</article-title>. <source>Stem Cell Res Ther</source>. <year>2022</year>;<volume>13</volume>(<issue>1</issue>):<fpage>356</fpage>.<pub-id pub-id-type="pmid">35883127</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s13287-022-03041-5</pub-id><pub-id pub-id-type="pmcid">PMC9327386</pub-id></mixed-citation></ref><ref id="ame270053-bib-0160"><label>160</label><mixed-citation publication-type="journal" id="ame270053-cit-0160"><string-name name-style="western"><surname>Meivar&#8208;Levy</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Zoabi</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Nardini</surname><given-names>G</given-names></string-name>, et&#160;al. <article-title>The role of the vasculature niche on insulin&#8208;producing cells generated by transdifferentiation of adult human liver cells</article-title>. <source>Stem Cell Res Ther</source>. <year>2019</year>;<volume>10</volume>:<fpage>53</fpage>.<pub-id pub-id-type="pmid">30760321</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s13287-019-1157-5</pub-id><pub-id pub-id-type="pmcid">PMC6373031</pub-id></mixed-citation></ref><ref id="ame270053-bib-0161"><label>161</label><mixed-citation publication-type="journal" id="ame270053-cit-0161"><string-name name-style="western"><surname>Rostami</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Kasaeian</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Maleki</surname><given-names>N</given-names></string-name>, et&#160;al. <article-title>The effect of bone marrow&#8208;derived mesenchymal stem cell co&#8208;transplantation with hematopoietic stem cells on liver fibrosis alleviation and survival in patients with class III &#946;&#8208;thalassemia major</article-title>. <source>Stem Cell Res Ther</source>. <year>2021</year>;<volume>12</volume>(<issue>1</issue>):<fpage>213</fpage>.<pub-id pub-id-type="pmid">33781314</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s13287-021-02242-8</pub-id><pub-id pub-id-type="pmcid">PMC8008651</pub-id></mixed-citation></ref><ref id="ame270053-bib-0162"><label>162</label><mixed-citation publication-type="journal" id="ame270053-cit-0162"><string-name name-style="western"><surname>Yao</surname><given-names>YQ</given-names></string-name>, <string-name name-style="western"><surname>Xia</surname><given-names>ZM</given-names></string-name>, <string-name name-style="western"><surname>Cheng</surname><given-names>FY</given-names></string-name>, et&#160;al. <article-title>Human placental mesenchymal stem cells ameliorate liver fibrosis in mice by upregulation of Caveolin1 in hepatic stellate cells</article-title>. <source>Stem Cell Res Ther</source>. <year>2021</year>;<volume>12</volume>(<issue>1</issue>):<fpage>294</fpage>.<pub-id pub-id-type="pmid">34016164</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s13287-021-02358-x</pub-id><pub-id pub-id-type="pmcid">PMC8139101</pub-id></mixed-citation></ref><ref id="ame270053-bib-0163"><label>163</label><mixed-citation publication-type="journal" id="ame270053-cit-0163"><string-name name-style="western"><surname>Wang</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>van</surname><given-names>HQT</given-names></string-name>, <string-name name-style="western"><surname>Seino</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></string-name>. <article-title>Reducing functionally defective old HSCs alleviates aging&#8208;related phenotypes in old recipient mice</article-title>. <source>Cell Res</source>. <year>2025</year>;<volume>35</volume>(<issue>1</issue>):<fpage>45</fpage>&#8208;<lpage>58</lpage>.<pub-id pub-id-type="pmid">39743633</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41422-024-01057-5</pub-id><pub-id pub-id-type="pmcid">PMC11701126</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>